{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:01:47Z","timestamp":1775001707187,"version":"3.50.1"},"reference-count":298,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/MULTI\/04046\/2019"],"award-info":[{"award-number":["UID\/MULTI\/04046\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTFC\/BIM-MEC\/3749\/2014"],"award-info":[{"award-number":["PTFC\/BIM-MEC\/3749\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00018-021-03809-7","type":"journal-article","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T01:02:36Z","timestamp":1616374956000},"page":"4677-4701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Nonsense suppression therapies in human genetic diseases"],"prefix":"10.1007","volume":"78","author":[{"given":"Patr\u00edcia","family":"Martins-Dias","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5061-5287","authenticated-orcid":false,"given":"Lu\u00edsa","family":"Rom\u00e3o","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"key":"3809_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/humu.20763","volume":"29","author":"M Mort","year":"2008","unstructured":"Mort M, Ivanov D, Cooper DN, Chuzhanova NA (2008) A meta-analysis of nonsense mutations causing human genetic disease. Hum Mutat 29:1037\u20131047","journal-title":"Hum Mutat"},{"key":"3809_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/1479-7364-2-5-274","volume":"2","author":"S Savas","year":"2006","unstructured":"Savas S, Tuzmen S, Ozcelik H (2006) Human SNPs resulting in premature stop codons and protein truncation. Hum Genomics 2:274\u2013286","journal-title":"Hum Genomics"},{"key":"3809_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/0092-8674(81)90396-2","volume":"27","author":"LE Maquat","year":"1981","unstructured":"Maquat LE, Kinniburgh AJ, Ross J (1981) Unstable \u03b2-globin mRNA in \u03b2-thalassemia. Cell 27:543\u2013553","journal-title":"Cell"},{"key":"3809_CR4","first-page":"235","volume":"2","author":"J Zhang","year":"1996","unstructured":"Zhang J, Maquat LE (1996) Evidence that the decay of nucleus-associated nonsense mRNA for human triosephosphate isomerase involves nonsense codon recognition after splicing. RNA 2:235\u2013243","journal-title":"RNA"},{"key":"3809_CR5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/ng1403","volume":"36","author":"JA Holbrook","year":"2004","unstructured":"Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE (2004) Nonsense-mediated decay approaches the clinic. Nat Genet 36:801\u2013808","journal-title":"Nat Genet"},{"key":"3809_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-genet-111212-133424","volume":"47","author":"MW-L Popp","year":"2013","unstructured":"Popp MW-L, Maquat LE (2013) Organizing principles of mammalian nonsense-mediated mRNA decay. Annu Rev Genet 47:139\u2013165","journal-title":"Annu Rev Genet"},{"key":"3809_CR7","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/hmg\/8.10.1893","volume":"8","author":"PA Frischmeyer","year":"1999","unstructured":"Frischmeyer PA, Dietz HC (1999) Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 8:1893\u20131900","journal-title":"Hum Mol Genet"},{"key":"3809_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/nar\/23.3.413","volume":"13","author":"W Kugler","year":"1995","unstructured":"Kugler W, Enssle J, Hentze MW, Kulozik AE (1995) Nuclear degradation of nonsense mutated \u03b2-globin mRNA: a post-transcriptional mechanism to protect heterozygotes from severe clinical manifestations of \u03b2-thalassemia? Nucleic Acids Res 13:413\u2013418","journal-title":"Nucleic Acids Res"},{"key":"3809_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1182\/blood.V89.1.322","volume":"89","author":"PJ Ho","year":"1997","unstructured":"Ho PJ, Wickramasinghe SN, Rees DC, Lee MJ, EdenThein A (1997) Erythroblastic inclusions in dominantly inherited beta thalassemias. Blood 89:322\u2013328","journal-title":"Blood"},{"key":"3809_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153527","volume":"15","author":"KM Keeling","year":"2014","unstructured":"Keeling KM, Xue X, Gunn G, Bedwell DM (2014) Therapeutics based on stop codon readthrough. Annu Rev Genomics Hum Genet 15:371\u2013394","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"3809_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/wrna.95","volume":"2","author":"KM Keeling","year":"2011","unstructured":"Keeling KM, Bedwell DM (2011) Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases. Wiley Interdiscip Rev RNA 2:837\u2013852","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"3809_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.pharmthera.2012.07.007","volume":"136","author":"H-LR Lee","year":"2012","unstructured":"Lee H-LR, Dougherty JP (2012) Pharmaceutical therapies to recode nonsense mutations in inherited diseases. Pharmacol Ther 136:227\u2013266","journal-title":"Pharmacol Ther"},{"key":"3809_CR13","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.3390\/ijms21124394","volume":"21","author":"P Morais","year":"2020","unstructured":"Morais P, Adachi H, Yu YT (2020) Suppression of nonsense mutations by new emerging technologies. Int J Mol Sci 21:4394","journal-title":"Int J Mol Sci"},{"key":"3809_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1146\/annurev-biochem-060713-035802","volume":"83","author":"AG Hinnebusch","year":"2014","unstructured":"Hinnebusch AG (2014) The scanning mechanism of eukaryotic translation initiation. Annu Rev Biochem 83:779\u2013812","journal-title":"Annu Rev Biochem"},{"key":"3809_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nrm2838","volume":"11","author":"RJ Jackson","year":"2010","unstructured":"Jackson RJ, Hellen CUT, Pestova TV (2010) The mechanism of eukaryotic translation initiation. Nat Rev Mol Cell Biol 11:113\u2013127","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3809_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature12355","volume":"500","author":"B Lomakin Ivan","year":"2013","unstructured":"Lomakin Ivan B, Steitz Thomas A (2013) The initiation of mammalian protein synthesis and the mechanism of scanning. Nature 500:307\u2013311","journal-title":"Nature"},{"key":"3809_CR17","doi-asserted-by":"publisher","first-page":"e1473","DOI":"10.1002\/wrna.1473","volume":"9","author":"NE Shirokikh","year":"2018","unstructured":"Shirokikh NE, Preiss T (2018) Translation initiation by cap-dependent ribosome recruitment: recent insights and open questions. Wiley Interdiscip Rev RNA 9:e1473","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"3809_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a013706","volume":"4","author":"TE Dever","year":"2012","unstructured":"Dever TE, Green R (2012) The elongation, termination, and recycling phases of translation in eukaryotes. Cold Spring Harb Perspect Biol 4:1\u201316","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3809_CR19","doi-asserted-by":"publisher","first-page":"a032649","DOI":"10.1101\/cshperspect.a032649","volume":"10","author":"TE Dever","year":"2018","unstructured":"Dever TE, Dinman JD, Green R (2018) Translation elongation and recoding in eukaryotes. Cold Spring Harb Perspect Biol 10:a032649","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3809_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41580-018-0011-4","volume":"19","author":"AP Schuller","year":"2018","unstructured":"Schuller AP, Green R (2018) Roadblocks and resolutions in eukaryotic translation. Nat Rev Mol Cell Biol 19:526\u2013541","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3809_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/372701a0","volume":"372","author":"L Frolova","year":"1994","unstructured":"Frolova L, Goff XL, Rasmussen HH et al (1994) A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor. Nature 372:701\u2013703","journal-title":"Nature"},{"key":"3809_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature14896","volume":"524","author":"A Brown","year":"2015","unstructured":"Brown A, Shao S, Murray J, Hegde RS, Ramakrishnan V (2015) Structural basis for stop codon recognition in eukaryotes. Nature 524:493\u2013496","journal-title":"Nature"},{"key":"3809_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0092-8674(00)80667-4","volume":"100","author":"H Song","year":"2000","unstructured":"Song H, Mugnier P, Das Amit K, Tuite MF, Hemmings BA, Barford D (2000) The crystal structure of human eukaryotic release factor eRF1\u2014mechanism of stop codon recognition and peptidyl-tRNA hydrolysis. Cell 100:311\u2013321","journal-title":"Cell"},{"key":"3809_CR24","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1002\/j.1460-2075.1995.tb00078.x","volume":"14","author":"G Zhouravleva","year":"1995","unstructured":"Zhouravleva G, Frolova L, Goff XL, Guellec RL, Inge-vechtomov S, Kisselev L, Philippe M, Zhouravleva G (1995) Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3 Xenopus SUP35C. EMBO J 14:4065\u20134072","journal-title":"EMBO J"},{"key":"3809_CR25","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1002\/j.1460-2075.1995.tb00111.x","volume":"14","author":"I Stansfield","year":"1995","unstructured":"Stansfield I, Jones KM, Kushnirov VV, Dagkesamanskaya AR, Poznyakovski AI, Paushkin SV, Nierras CR, Cox BS, Ter-Avanesyan MD, Tuite MF (1995) The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J 14:4365\u20134373","journal-title":"EMBO J"},{"key":"3809_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a032656","volume":"10","author":"CUT Hellen","year":"2018","unstructured":"Hellen CUT (2018) Translation termination and ribosome recycling in eukaryotes. Cold Spring Harb Perspect Biol 10:1\u201319","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3809_CR27","doi-asserted-by":"publisher","first-page":"7766","DOI":"10.1093\/nar\/gkw635","volume":"44","author":"A Ivanov","year":"2016","unstructured":"Ivanov A, Mikhailova T, Eliseev B, Yeramala L, Sokolova E, Susorov D, Shuvalov A, Schaffitzel C, Alkalaeva E (2016) PABP enhances release factor recruitment and stop codon recognition during translation termination. Nucleic Acids Res 44:7766\u20137776","journal-title":"Nucleic Acids Res"},{"key":"3809_CR28","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/nar\/gkw1239","volume":"45","author":"T Mikhailova","year":"2017","unstructured":"Mikhailova T, Shuvalova E, Ivanov A, Susorov D, Shuvalov A, Kolosov PM, Alkalaeva E (2017) RNA helicase DDX19 stabilizes ribosomal elongation and termination complexes. Nucleic Acids Res 45:1307\u20131318","journal-title":"Nucleic Acids Res"},{"key":"3809_CR29","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1093\/nar\/gkz177","volume":"47","author":"C Bei\u00dfel","year":"2019","unstructured":"Bei\u00dfel C, Neumann B, Uhse S, Hampe I, Karki P, Krebber H (2019) Translation termination depends on the sequential ribosomal entry of eRF1 and eRF3. Nucleic Acids Res 47:4798\u20134813","journal-title":"Nucleic Acids Res"},{"key":"3809_CR30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.molcel.2009.12.034","volume":"37","author":"AV Pisarev","year":"2010","unstructured":"Pisarev AV, Skabkin MA, Pisareva VP, Skabkina OV, Rakotondrafara AM, Hentze MW, Hellen CUT, Pestova TV (2010) The role of ABCE1 in eukaryotic posttermination ribosomal recycling. Mol Cell 37:196\u2013210","journal-title":"Mol Cell"},{"key":"3809_CR31","doi-asserted-by":"publisher","first-page":"10259","DOI":"10.1093\/nar\/gkaa758","volume":"48","author":"G Annibaldis","year":"2020","unstructured":"Annibaldis G, Domanski M, Dreos R, Contu L, Carl S, Kl\u00e4y N, M\u00fchlemann O (2020) Readthrough of stop codons under limiting ABCE1 concentration involves frameshifting and inhibits nonsense-mediated mRNA decay. Nucleic Acids Res 48:10259\u201310279","journal-title":"Nucleic Acids Res"},{"key":"3809_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2007.08.041","volume":"131","author":"AV Pisarev","year":"2007","unstructured":"Pisarev AV, Hellen CUTT, Pestova TV (2007) Recycling of eukaryotic posttermination ribosomal complexes. Cell 131:286\u2013299","journal-title":"Cell"},{"key":"3809_CR33","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1093\/nar\/25.12.2254","volume":"25","author":"G Drugeon","year":"1997","unstructured":"Drugeon G, Jean-Jean O, Frolova L, Le G, Philippe M, Kisselev L, Haenni AL (1997) Eukaryotic release factor 1 (eRF1) abolishes readthrough and competes with suppressor tRNAs at all three termination codons in messenger RNA. Nucleic Acids Res 25:2254\u20132258","journal-title":"Nucleic Acids Res"},{"key":"3809_CR34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1006\/jmbi.1995.0438","volume":"251","author":"B Bonetti","year":"1995","unstructured":"Bonetti B, Bedwell DM (1995) The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae. J Mol Biol 251:334\u2013345","journal-title":"J Mol Biol"},{"key":"3809_CR35","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1080\/15476286.2015.1068497","volume":"12","author":"M Dabrowski","year":"2015","unstructured":"Dabrowski M, Bukowy-Bieryllo Z, Zietkiewicz E (2015) Translational readthrough potential of natural termination codons in eucaryotes\u2014the impact of RNA sequence. RNA Biol 12:950\u2013958","journal-title":"RNA Biol"},{"key":"3809_CR36","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1016\/S0021-9258(17)32379-7","volume":"269","author":"K Fearon","year":"1994","unstructured":"Fearon K, Mcclendon V, Bonetti B, Bedwell DM (1994) Premature translation termination mutations are efficiently suppressed in a highly conserved region of yeast Ste6p, a member of the ATP-binding cassette (ABC) transporter family. J Biol Chem 269:17802\u201317808","journal-title":"J Biol Chem"},{"key":"3809_CR37","doi-asserted-by":"publisher","first-page":"e1002608","DOI":"10.1371\/journal.pgen.1002608","volume":"8","author":"C Floquet","year":"2012","unstructured":"Floquet C, Hatin I, Rousset J-P, Bidou L (2012) Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin. PLoS Genet 8:e1002608","journal-title":"PLoS Genet"},{"key":"3809_CR38","doi-asserted-by":"publisher","first-page":"8928","DOI":"10.1093\/nar\/gku608","volume":"42","author":"G Loughran","year":"2014","unstructured":"Loughran G, Chou M-Y, Ivanov IP, Jungreis I, Kellis M, Kiran AM, Baranov PV, Atkins JF (2014) Evidence of efficient stop codon readthrough in four mammalian genes. Nucleic Acids Res 42:8928\u20138938","journal-title":"Nucleic Acids Res"},{"key":"3809_CR39","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/embo-reports\/kve176","volume":"2","author":"O Namy","year":"2001","unstructured":"Namy O, Hatin I, Rousset J-P (2001) Impact of the six nucleotides downstream of the stop codon on translation termination. EMBO Rep 2:787\u2013793","journal-title":"EMBO Rep"},{"key":"3809_CR40","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1093\/nar\/gkx1315","volume":"46","author":"AG Cridge","year":"2018","unstructured":"Cridge AG, Crowe-McAuliffe C, Mathew SF, Tate WP (2018) Eukaryotic translational termination efficiency is influenced by the 3\u2032 nucleotides within the ribosomal mRNA channel. Nucleic Acids Res 46:1927\u20131944","journal-title":"Nucleic Acids Res"},{"key":"3809_CR41","doi-asserted-by":"publisher","first-page":"5431","DOI":"10.1073\/pnas.92.12.5431","volume":"92","author":"KK McCaughan","year":"1995","unstructured":"McCaughan KK, Brown CM, Dalphin ME, Berry MJ, Tate WP (1995) Translational termination efficiency in mammals is influenced by the base following the stop codon. Proc Natl Acad Sci USA 92:5431\u20135435","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-4939-6937-1_9","volume":"1595","author":"J Hofhuis","year":"2017","unstructured":"Hofhuis J, Dieterle S, George R, Schueren F, Thoms S (2017) Dual reporter systems for the analysis of translational readthrough in mammals. Methods Mol Biol 1595:81\u201392","journal-title":"Methods Mol Biol"},{"key":"3809_CR43","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1128\/EC.00090-14","volume":"13","author":"M Peccarelli","year":"2014","unstructured":"Peccarelli M, Kebaara BW (2014) Regulation of natural mRNAs by the nonsense-mediated mRNA decay pathway. Eukarytic Cell 13:1126\u20131135","journal-title":"Eukarytic Cell"},{"key":"3809_CR44","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1126\/science.aax2957","volume":"366","author":"SL Wolin","year":"2019","unstructured":"Wolin SL, Maquat LE (2019) Cellular RNA surveillance in health and disease. Science 366:822\u2013882","journal-title":"Science"},{"key":"3809_CR45","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/embo-reports\/kve128","volume":"2","author":"P Steneberg","year":"2001","unstructured":"Steneberg P, Samakovlis C (2001) A novel stop codon readthrough mechanism produces functional Headcase protein in Drosophila trachea. EMBO Rep 2:593\u2013597","journal-title":"EMBO Rep"},{"key":"3809_CR46","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1093\/nar\/gkr224","volume":"39","author":"AE Firth","year":"2011","unstructured":"Firth AE, Wills NM, Gesteland RF, Atkins JF (2011) Stimulation of stop codon readthrough: frequent presence of an extended 3\u2019 RNA structural element. Nucleic Acids Res 39:6679\u20136691","journal-title":"Nucleic Acids Res"},{"key":"3809_CR47","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature10165","volume":"474","author":"J Karijolich","year":"2011","unstructured":"Karijolich J, Yu Y-T (2011) Converting nonsense codons into sense codons by targeted pseudouridylation. Nature 474:395\u2013398","journal-title":"Nature"},{"key":"3809_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03060","volume":"432","author":"N Amrani","year":"2004","unstructured":"Amrani N, Ganesan R, Kervestin S, Mangus DA, Ghosh S, Jacobson A (2004) A faux 3\u2032-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay. Nature 432:112\u2013118","journal-title":"Nature"},{"key":"3809_CR49","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1093\/nar\/gkz346","volume":"47","author":"P Beznoskov\u00e1","year":"2019","unstructured":"Beznoskov\u00e1 P, Pavl\u00edkov\u00e1 Z, Zeman J, Aitken CE, Val\u00e1\u0161ek LS (2019) Yeast applied readthrough inducing system (YARIS): an invivo assay for the comprehensive study of translational readthrough. Nucleic Acids Res 47:6339\u20136350","journal-title":"Nucleic Acids Res"},{"key":"3809_CR50","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1093\/nar\/gkv154","volume":"43","author":"S Blanchet","year":"2015","unstructured":"Blanchet S, Rowe M, Haar TVD, Fabret C, Demais S, Howard MJ, Namy O (2015) New insights into stop codon recognition by eRF1. Nucleic Acids Res 43:3298\u20133308","journal-title":"Nucleic Acids Res"},{"key":"3809_CR51","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1073\/pnas.1424127112","volume":"112","author":"B Roy","year":"2015","unstructured":"Roy B, Leszyk JD, Mangus DA, Jacobson A (2015) Nonsense suppression by near-cognate tRNAs employs alternative base pairing at codon positions 1 and 3. Proc Natl Acad Sci USA 112:3038\u20133043","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR52","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1073\/pnas.1311750111","volume":"111","author":"C Loenarz","year":"2014","unstructured":"Loenarz C, Sekirnik R, Armin Thalhammer A et al (2014) Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy. Proc Natl Acad Sci USA 111:4019\u20134024","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR53","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.molmed.2012.09.008","volume":"18","author":"L Bidou","year":"2012","unstructured":"Bidou L, Allamand V, Rousset J-P, Namy O (2012) Sense from nonsense: therapies for premature stop codon diseases. Trends Mol Med 18:679\u2013688","journal-title":"Trends Mol Med"},{"key":"3809_CR54","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/sj.gt.3302211","volume":"11","author":"L Bidou","year":"2004","unstructured":"Bidou L, Hatin I, Perez N, Allamand V, Panthier JJ, Rousset JP (2004) Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment. Gene Ther 11:619\u2013627","journal-title":"Gene Ther"},{"key":"3809_CR55","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1101\/gr.119974.110","volume":"21","author":"I Jungreis","year":"2011","unstructured":"Jungreis I, Lin MF, Spokony R, Chan CS, Negre N, Victorsen A, White KP, Kellis M (2011) Evidence of abundant stop codon readthrough in Drosophila and other metazoa. Genome Res 21:2096\u20132113","journal-title":"Genome Res"},{"key":"3809_CR56","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1017\/S1355838200000716","volume":"6","author":"M Manuvakhova","year":"2000","unstructured":"Manuvakhova M, Keeling K, Bedwell DM (2000) Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. RNA 6:1044\u20131055","journal-title":"RNA"},{"key":"3809_CR57","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B","volume":"48","author":"MT Howard","year":"2000","unstructured":"Howard MT, Shirts BH, Petros LM, Flanigan KM, Gesteland RF, Atkins JF (2000) Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy. Ann Neurol 48:164\u2013116","journal-title":"Ann Neurol"},{"key":"3809_CR58","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1128\/jvi.67.8.5062-5067.1993","volume":"67","author":"G Li","year":"1993","unstructured":"Li G, Rice CM (1993) The signal for translational readthrough of a UGA codon in Sindbis virus RNA involves a single cytidine residue immediately downstream of the termination codon. J Virol 67:5062\u20135067","journal-title":"J Virol"},{"key":"3809_CR59","first-page":"e52611","volume":"9","author":"JR Wangen","year":"2020","unstructured":"Wangen JR, Green R (2020) Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides. Chromosom Gene Expr 9:e52611","journal-title":"Chromosom Gene Expr"},{"key":"3809_CR60","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/nar\/30.9.2011","volume":"30","author":"L Harrell","year":"2017","unstructured":"Harrell L, Melcher U, Atkins JF (2017) Predominance of six different hexanucleotide recoding signals 3\u2032 of read-through stop codons. Nucleic Acids Res 30:2011\u20132017","journal-title":"Nucleic Acids Res"},{"key":"3809_CR61","doi-asserted-by":"publisher","first-page":"e1004392","DOI":"10.1371\/journal.pgen.1004392","volume":"10","author":"FFV Chevance","year":"2014","unstructured":"Chevance FFV, Guyon SL, Hughes KT (2014) The effects of codon context on in vivo translation speed. PLoS Genet 10:e1004392","journal-title":"PLoS Genet"},{"key":"3809_CR62","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/nar\/gkh201","volume":"32","author":"S Tork","year":"2004","unstructured":"Tork S, Hatin I, Rousset JP, Fabret C (2004) The major 5\u2032 determinant in stop codon read-through involves two adjacent adenines. Nucleic Acids Res 32:415\u2013421","journal-title":"Nucleic Acids Res"},{"key":"3809_CR63","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1126\/science.1134641","volume":"315","author":"T Gross","year":"2007","unstructured":"Gross T, Siepmann A, Sturm D, Windgassen M, Scarcelli JJ, Seedorf M, Cole CN, Krebber H (2007) The DEAD-box RNA helicase Dbp5 functions in translation termination. Science 315:646\u2013649","journal-title":"Science"},{"key":"3809_CR64","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11051","volume":"485","author":"J Freitag","year":"2012","unstructured":"Freitag J, Ast J, B\u00f6lker M (2012) Cryptic peroxisomal targeting via alternative splicing and stop codon read-through in fungi. Nature 485:522\u2013525","journal-title":"Nature"},{"key":"3809_CR65","first-page":"e01179","volume":"2","author":"JG Dunn","year":"2013","unstructured":"Dunn JG (2013) Ribosome profiling reveals pervasive and regulated stop codon readthrough in Drosophila melanogaster. Cell Biol Evol Biol 2:e01179","journal-title":"Cell Biol Evol Biol"},{"key":"3809_CR66","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1074\/jbc.M117.818526","volume":"293","author":"G Loughran","year":"2018","unstructured":"Loughran G, Jungreis I, Tzani I, Power M, Dmitriev RI, Ivanov IP, Kellis M, Atkins JF (2018) Stop codon readthrough generates a C-terminally extended variant of the human vitamin D receptor with reduced calcitriol response. J Biol Chem 293:4434\u20134444","journal-title":"J Biol Chem"},{"key":"3809_CR67","doi-asserted-by":"publisher","first-page":"17765","DOI":"10.1074\/jbc.M111.314468","volume":"287","author":"Y Yamaguchi","year":"2012","unstructured":"Yamaguchi Y, Hayashi A, Campagnoni CW, Kimura A, Inuzuka T, Baba H (2012) L-MPZ, a novel isoform of myelin P0, is produced by stop codon readthrough. J Biol Chem 287:17765\u201317776","journal-title":"J Biol Chem"},{"key":"3809_CR68","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.cell.2014.04.033","volume":"157","author":"SM Eswarappa","year":"2014","unstructured":"Eswarappa SM, Potdar AA, Koch WJ, Fan Y, Vasu K, Lindner D, Willard B, Graham LM, DiCorleto PE, Fox PL (2014) Programmed translational readthrough generates antiangiogenic VEGF-Ax. Cell 157:1605\u20131618","journal-title":"Cell"},{"key":"3809_CR69","first-page":"e03640","volume":"3","author":"F Schueren","year":"2014","unstructured":"Schueren F, Lingner T, George R, Hofhuis J, Dickel C, G\u00e4rtner J, Thoms S (2014) Peroxisomal lactate dehydrogenase is generated by translational readthrough in mammals. Cell Biol Evol Biol 3:e03640","journal-title":"Cell Biol Evol Biol"},{"key":"3809_CR70","doi-asserted-by":"publisher","first-page":"e1004685","DOI":"10.1371\/journal.pgen.1004685","volume":"10","author":"AC Stiebler","year":"2014","unstructured":"Stiebler AC, Freitag J, Schink KO, Stehlik T, Tillmann BAM, Ast J, B\u00f6lker M (2014) Ribosomal readthrough at a short UGA stop codon context triggers dual localization of metabolic enzymes in Fungi and animals. PLoS Genet 10:e1004685","journal-title":"PLoS Genet"},{"key":"3809_CR71","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1093\/nar\/gkv421","volume":"43","author":"P Beznoskov\u00e1","year":"2015","unstructured":"Beznoskov\u00e1 P, Wagner S, Jansen ME, Haar TVD, Val\u00e1\u0161ek LS (2015) Translation initiation factor eIF3 promotes programmed stop codon readthrough. Nucleic Acids Res 43:5099\u201350111","journal-title":"Nucleic Acids Res"},{"key":"3809_CR72","doi-asserted-by":"publisher","first-page":"e100727","DOI":"10.15252\/embj.2018100727","volume":"38","author":"A Singh","year":"2019","unstructured":"Singh A, Manjunath LE, Kundu P, Sahoo S, Das A, Suma HR, Fox PL, Eswarappa SM (2019) Let-7a-regulated translational readthrough of mammalian AGO1 generates a microRNA pathway inhibitor. EMBO J 38:e100727","journal-title":"EMBO J"},{"key":"3809_CR73","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.febslet.2008.12.058","volume":"583","author":"AL Silva","year":"2009","unstructured":"Silva AL, Rom\u00e3o L (2009) The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! Which players make the decision? FEBS Lett 583:499\u2013505","journal-title":"FEBS Lett"},{"key":"3809_CR74","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tibs.2006.09.005","volume":"31","author":"J Rehwinkel","year":"2006","unstructured":"Rehwinkel J, Raes J, Izaurralde E (2006) Nonsense-mediated mRNA decay: target genes and functional diversification of effectors. Trends Biochem Sci 31:639\u2013646","journal-title":"Trends Biochem Sci"},{"key":"3809_CR75","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/ng1429","volume":"36","author":"JT Mendell","year":"2004","unstructured":"Mendell JT, Sharifi NA, Meyers JL, Martinez-Murillo F, Dietz HC (2004) Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat Genet 36:1073\u20131078","journal-title":"Nat Genet"},{"key":"3809_CR76","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0092-8674(01)00583-9","volume":"107","author":"JT Mendell","year":"2001","unstructured":"Mendell JT, Dietz HC (2001) When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 107:411\u2013414","journal-title":"Cell"},{"key":"3809_CR77","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00018-009-0177-1","volume":"67","author":"P Nicholson","year":"2010","unstructured":"Nicholson P, Yepiskoposyan H, Metze S, Orozco RZ, Kleinschmidt N, M\u00fchlemann O (2010) Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell Mol Life Sci 67:677\u2013700","journal-title":"Cell Mol Life Sci"},{"key":"3809_CR78","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/nar\/gkw010","volume":"44","author":"N Hug","year":"2016","unstructured":"Hug N, Longman D, C\u00e1ceres JF (2016) Mechanism and regulation of the nonsense-mediated decay pathway. Nucleic Acids Res 44:1483\u20131495","journal-title":"Nucleic Acids Res"},{"key":"3809_CR79","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4161\/rna.7.1.10578","volume":"7","author":"O M\u00fchlemann","year":"2010","unstructured":"M\u00fchlemann O, Lykke-Andersen J (2010) How and where are nonsense mRNAs degraded in mammalian cells? RNA Biol 7:28\u201332","journal-title":"RNA Biol"},{"key":"3809_CR80","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1105\/tpc.19.00666","volume":"32","author":"WC Lee","year":"2020","unstructured":"Lee WC, Hou BH, Hou CY, Tsao SM, Kao P, Chen HM (2020) Widespread exon junction complex footprints in the RNA degradome mark mRNA degradation before steady state translation. Plant Cell 32:904\u2013922","journal-title":"Plant Cell"},{"key":"3809_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12030765","volume":"12","author":"K Pawlicka","year":"2020","unstructured":"Pawlicka K, Kalathiya U, Alfaro J (2020) Nonsense-mediated mRNA decay: Pathologies and the potential for novel therapeutics. Cancers 12:1\u201317","journal-title":"Cancers"},{"key":"3809_CR82","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1101\/gad.1407606","volume":"20","author":"I Behm-Ansmant","year":"2006","unstructured":"Behm-Ansmant I, Izaurralde E (2006) Quality control of gene expression: a stepwise assembly pathway for the surveillance complex that triggers nonsense-mediated mRNA decay. Genes Dev 20:391\u2013398","journal-title":"Genes Dev"},{"key":"3809_CR83","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.semcdb.2017.08.053","volume":"75","author":"S Nasif","year":"2018","unstructured":"Nasif S, Contu L, M\u00fchlemann O (2018) Beyond quality control: The role of nonsense-mediated mRNA decay (NMD) in regulating gene expression. Semin Cell Dev Biol 75:78\u201387","journal-title":"Semin Cell Dev Biol"},{"key":"3809_CR84","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrm4063","volume":"16","author":"S Lykke-Andersen","year":"2015","unstructured":"Lykke-Andersen S, Jensen TH (2015) Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes. Nat Rev Mol Cell Biol 16:665\u2013677","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3809_CR85","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1186\/gb-2009-10-9-r101","volume":"10","author":"AK Ramani","year":"2009","unstructured":"Ramani AK, Nelson AC, Kapranov P, Bell I, Gingeras TR, Fraser AG (2009) High resolution transcriptome maps for wild-type and nonsense-mediated decay-defective Caenorhabditis elegans. Genome Biol 10:R101","journal-title":"Genome Biol"},{"key":"3809_CR86","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1101\/gr.130559.111","volume":"22","author":"H Tani","year":"2012","unstructured":"Tani H, Mizutani R, Salam KA, Tano K, Ijiri K, Wakamatsu A, Isogai T, Suzuki Y, Akimitsu N (2012) Genome-wide determination of RNA stability reveals hundreds of short-lived noncoding transcripts in mammals. Genome Res 22:947\u2013956","journal-title":"Genome Res"},{"key":"3809_CR87","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.4161\/rna.22036","volume":"9","author":"H Tani","year":"2012","unstructured":"Tani H, Akimitsu N (2012) Genome-wide technology for determining RNA stability in mammalian cells: historical perspective and recent advantages based on modified nucleotide labeling. RNA Biol 9:1233\u20131238","journal-title":"RNA Biol"},{"key":"3809_CR88","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1261\/rna.030247.111","volume":"17","author":"H Yepiskoposyan","year":"2011","unstructured":"Yepiskoposyan H, Aeschimann F, Nilsson D, Okoniewski M, M\u00fchlemann O (2011) Autoregulation of the nonsense-mediated mRNA decay pathway in human cells. RNA 17:2108\u20132118","journal-title":"RNA"},{"key":"3809_CR89","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1083\/jcb.200611086","volume":"178","author":"S Durand","year":"2007","unstructured":"Durand S, Cougot N, Mahuteau-Betzer F, Nguyen C-H, Grierson DS, Bertrand E, Tazi J, Lejeune F (2007) Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies. J Cell Biol 178:1145\u20131160","journal-title":"J Cell Biol"},{"key":"3809_CR90","doi-asserted-by":"publisher","first-page":"8936","DOI":"10.1074\/jbc.270.15.8936","volume":"270","author":"CC Oliveira","year":"1995","unstructured":"Oliveira CC, McCarthy JE (1995) The relationship between eukaryotic translation and mRNA stability. A short upstream open reading frame strongly inhibits translational initiation and greatly accelerates mRNA degradation in the yeast Saccharomyces cerevisiae. J Biol Chem 270:8936\u20138943","journal-title":"J Biol Chem"},{"key":"3809_CR91","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1371\/journal.pbio.0060092","volume":"6","author":"AB Eberle","year":"2008","unstructured":"Eberle AB, Stalder L, Mathys H, Orozco RZ, M\u00fchlemann O (2008) Posttranscriptional gene regulation by spatial rearrangement of the 3\u2032 untranslated region. PLoS Biol 6:e92","journal-title":"PLoS Biol"},{"key":"3809_CR92","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1371\/journal.pbio.0060111","volume":"6","author":"G Singh","year":"2008","unstructured":"Singh G, Rebbapragada I, Lykke-Andersen J (2008) A competition between stimulators and antagonists of Upf complex recruitment governs human nonsense-mediated mRNA decay. PLoS Biol 6:e111","journal-title":"PLoS Biol"},{"key":"3809_CR93","doi-asserted-by":"publisher","first-page":"e1548","DOI":"10.1002\/wrna.1548","volume":"10","author":"A Kishor","year":"2019","unstructured":"Kishor A, Fritz SE, Hogg JR (2019) Nonsense-mediated mRNA decay: the challenge of telling right from wrong in a complex transcriptome. Wiley Interdiscip Rev RNA 10:e1548","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"3809_CR94","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-3-030-19966-1_3","volume":"1157","author":"R Fernandes","year":"2019","unstructured":"Fernandes R, Nogueira G, da Costa PJ, Pinto F, Rom\u00e3o L (2019) Nonsense-mediated mRNA decay in development, stress and cancer. Adv Exp Med Biol 1157:41\u201383","journal-title":"Adv Exp Med Biol"},{"key":"3809_CR95","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/346366a0","volume":"346","author":"GR Cutting","year":"1990","unstructured":"Cutting GR, Kasch LM, Rosenstein BJ, Zielenski J, Tsui LC, Antonarakis SE Jr, Kazazian HH (1990) A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature 346:366\u2013369","journal-title":"Nature"},{"key":"3809_CR96","doi-asserted-by":"publisher","first-page":"8447","DOI":"10.1073\/pnas.87.21.8447","volume":"87","author":"BS Kerem","year":"1990","unstructured":"Kerem BS, Zielenski J, Markiewicz D, Bozon D, Gazit E, Yahav J, Kennedy D, Riordan JR, Collins FS, Rommens JM (1990) Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci USA 87:8447\u20138451","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR97","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","volume":"27","author":"G Veit","year":"2016","unstructured":"Veit G, Avramescu RG, Chiang AN et al (2016) From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations. Mol Biol Cell 27:424\u2013433","journal-title":"Mol Biol Cell"},{"key":"3809_CR98","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1126\/scitranslmed.aad8278","volume":"8","author":"JF Dekkers","year":"2016","unstructured":"Dekkers JF, Berkers G, Kruisselbrink E et al (2016) Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis. Sci Transl Med 8:344\u2013384","journal-title":"Sci Transl Med"},{"key":"3809_CR99","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/jcm9020289","volume":"9","author":"M Borgatti","year":"2020","unstructured":"Borgatti M, Altamura E, Salvatori F, D\u2019Aversa E, Altamura N (2020) Screening readthrough compounds to suppress nonsense mutations: possible application to \u03b2-thalassemia. J Clin Med 9:289","journal-title":"J Clin Med"},{"key":"3809_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-17974-z","volume":"11","author":"ED Karousis","year":"2020","unstructured":"Karousis ED, Gurzeler L-A, Annibaldis G, Dreos R, M\u00fchlemann O (2020) Human NMD ensues independently of stable ribosome stalling. Nat Commun 11:1\u201312","journal-title":"Nat Commun"},{"key":"3809_CR101","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1073\/pnas.1715578115","volume":"115","author":"S Blanchet","year":"2018","unstructured":"Blanchet S, Cornu D, Hatin I, Grosjean H, Bertin P, Namy O (2018) Deciphering the reading of the genetic code by near-cognate tRNA. Proc Natl Acad Sci USA 115:3018\u20133023","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR102","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1093\/nar\/13.17.6265","volume":"13","author":"JF Burke","year":"1985","unstructured":"Burke JF, Mogg AE (1985) Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin. Nucleic Acids Res 13:6265\u20136272","journal-title":"Nucleic Acids Res"},{"key":"3809_CR103","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.3390\/s140203737","volume":"14","author":"N Nikolaus","year":"2014","unstructured":"Nikolaus N, Strehlitz B (2014) DNA-aptamers binding aminoglycoside antibiotics. Sensors 14:3737\u20133755","journal-title":"Sensors"},{"key":"3809_CR104","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1073\/pnas.51.5.883","volume":"51","author":"J Davies","year":"1964","unstructured":"Davies J, Gilbert W, Gorini L (1964) Streptomycin, suppression, and the code. Proc Natl Acad Sci USA 51:883\u2013890","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR105","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000013861","volume":"5","author":"A Forge","year":"2000","unstructured":"Forge A, Schacht J (2000) Aminoglycoside antibiotics. Audiol Neurootol 5:3\u201322","journal-title":"Audiol Neurootol"},{"key":"3809_CR106","doi-asserted-by":"publisher","first-page":"a027029","DOI":"10.1101\/cshperspect.a027029","volume":"6","author":"KM Krause","year":"2016","unstructured":"Krause KM, Serio AW, Kane TR, Connolly LE (2016) Aminoglycosides: an overview. Cold Spring Harb Perspect Med 6:a027029","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3809_CR107","first-page":"245","volume":"46","author":"D Obrecht","year":"2011","unstructured":"Obrecht D, Bernardini F, Dale G, Dembowsky K (2011) Emerging new therapeutics against key gram-negative pathogens. Annu Rep Med 46:245\u2013262","journal-title":"Annu Rep Med"},{"key":"3809_CR108","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1261\/rna.805208","volume":"14","author":"H Fan-Minogue","year":"2008","unstructured":"Fan-Minogue H, Bedwell DM (2008) Eukaryotic ribosomal RNA determinants of aminoglycoside resistance and their role in translational fidelity. RNA 14:148\u2013157","journal-title":"RNA"},{"key":"3809_CR109","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/327389a0","volume":"327","author":"D Moazed","year":"1987","unstructured":"Moazed D, Noller HF (1987) Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature 327:389\u2013394","journal-title":"Nature"},{"key":"3809_CR110","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.1093\/nar\/gki862","volume":"33","author":"B Fran\u00e7ois","year":"2005","unstructured":"Fran\u00e7ois B, Russell RJM, Murray JB, Aboul-ela F, Masquida B, Vicens Q, Westhof E (2005) Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding. Nucleic Acids Res 33:5677\u20135699","journal-title":"Nucleic Acids Res"},{"key":"3809_CR111","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1093\/emboj\/18.11.3133","volume":"18","author":"MI Recht","year":"1999","unstructured":"Recht MI, Douthwaite S, Puglisi JD (1999) Basis for prokaryotic specificity of action of aminoglycoside antibiotics. EMBO J 18:3133\u20133138","journal-title":"EMBO J"},{"key":"3809_CR112","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1006\/jmbi.2000.4420","volume":"306","author":"SR Lynch","year":"2001","unstructured":"Lynch SR, Puglisi JD (2001) Structural origins of aminoglycoside specificity for prokaryotic ribosomes. J Mol Biol 306:1037\u20131058","journal-title":"J Mol Biol"},{"key":"3809_CR113","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/157016005774913149","volume":"3","author":"KM Keeling","year":"2005","unstructured":"Keeling KM, Bedwell DM (2005) Pharmacological suppression of premature stop mutations that cause genetic diseases. Curr Pharmacogenomics 3:259\u2013269","journal-title":"Curr Pharmacogenomics"},{"key":"3809_CR114","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/cbic.200300657","volume":"4","author":"P Pfister","year":"2011","unstructured":"Pfister P, Hobbie S, Vicens Q, B\u00f6ttger EC, Westhof E (2011) The molecular basis for A-site mutations conferring aminoglycoside resistance: relationship between ribosomal susceptibility and X-ray crystal structures. ChemBioChem 4:1078\u20131088","journal-title":"ChemBioChem"},{"key":"3809_CR115","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1021\/bi00302a019","volume":"23","author":"DC Eustice","year":"1984","unstructured":"Eustice DC, Wilhelm JM (1984) Fidelity of the eukaryotic codon-anticodon interaction: interference by aminoglycoside antibiotics. Biochemisty 23:1462\u20131467","journal-title":"Biochemisty"},{"key":"3809_CR116","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B","volume":"48","author":"MT Howard","year":"2001","unstructured":"Howard MT, Shirts BH, Petros LM, Flanigan KM, Gesteland RF, Atkins JF (2001) Sequence specificity of aminoglycoside-induced stop codon readthrough: potential implications for treatment of Duchenne muscular dystrophy. Ann Neurol 48:164\u2013116","journal-title":"Ann Neurol"},{"key":"3809_CR117","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3109\/10409238.2012.694846","volume":"47","author":"KM Keeling","year":"2012","unstructured":"Keeling KM, Wang D, Conard SE, Bedwell DM (2012) Suppression of premature termination codons as a therapeutic approach. Crit Rev Biochem Mol Biol 47:444\u2013463","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"3809_CR118","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/diseases4040032","volume":"4","author":"KM Keeling","year":"2016","unstructured":"Keeling KM (2016) Nonsense suppression as an approach to treat lysosomal storage diseases. Diseases 4:32","journal-title":"Diseases"},{"key":"3809_CR119","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3324\/haematol.2018.212118","volume":"105","author":"L Martorell","year":"2020","unstructured":"Martorell L, Cortina V, Parra R, Barquinero J, Vidal F (2020) Variable readthrough responsiveness of nonsense mutations in Hemophilia A. Haematologica 105:508\u2013518","journal-title":"Haematologica"},{"key":"3809_CR120","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nm0496-467","volume":"2","author":"M Howard","year":"1996","unstructured":"Howard M, Frizzell RA, Bedwell DM (1996) Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med 2:467\u2013469","journal-title":"Nat Med"},{"key":"3809_CR121","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/nm1197-1280","volume":"3","author":"DM Bedwell","year":"1997","unstructured":"Bedwell DM, Kaenjak A, Benos DJ, Bebok Z, Bubien JK, Hong J, Tousson A, Clancy JP, Sorscher EJ (1997) Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line. Nat Med 3:1280\u20131284","journal-title":"Nat Med"},{"key":"3809_CR122","unstructured":"DrugBank (2005) Geneticin. In: DrugBank. https:\/\/www.drugbank.ca\/drugs\/DB04263. Accessed 15 Aug 2020"},{"key":"3809_CR123","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0167-4781(83)90018-0","volume":"741","author":"S Bar-Nun","year":"1983","unstructured":"Bar-Nun S, Beckmann JS (1983) G-418, an elongation inhibitor of 80 S ribosomes. Biochim Biophys Acta Gene Struct Expr 741:123\u2013127","journal-title":"Biochim Biophys Acta Gene Struct Expr"},{"key":"3809_CR124","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/exd.12655","volume":"24","author":"C Kuschal","year":"2015","unstructured":"Kuschal C, Khan SG, Enk B, DiGiovanna JJ, Kraemer KH (2015) Readthrough of stop codons by use of aminoglycosides in cells from xeroderma pigmentosum group C patients. Exp Dermatol 24:296\u2013297","journal-title":"Exp Dermatol"},{"key":"3809_CR125","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1093\/hmg\/ddn302","volume":"17","author":"M Moosajee","year":"2008","unstructured":"Moosajee M, Gregory-Evans K, Ellis CD, Seabra MC, Gregory-Evans CY (2008) Translational bypass of nonsense mutations in zebrafish rep1, pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease. Hum Mol Genet 17:3987\u20134000","journal-title":"Hum Mol Genet"},{"key":"3809_CR126","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/jnr.22409","volume":"88","author":"AC Popescu","year":"2010","unstructured":"Popescu AC, Sidorova E, Zhang G, Eubanks JH (2010) Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro. J Neurosci Res 88:2316\u20132324","journal-title":"J Neurosci Res"},{"key":"3809_CR127","doi-asserted-by":"publisher","first-page":"15676","DOI":"10.1073\/pnas.0405155101","volume":"101","author":"C-H Lai","year":"2004","unstructured":"Lai C-H, Chun HH, Nahas SA, Mitui M, Gamo KM, Du L, Gatti RA (2004) Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons. Proc Natl Acad Sci USA 101:15676\u201315681","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR128","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1021\/jm801640k","volume":"52","author":"I Nudelman","year":"2009","unstructured":"Nudelman I, Rebibo-Sabbah A, Cherniavsky M, Belakhov V, Hainrichson M, Chen F, Schacht J, Pilch DS, Ben-Yosef T, Baasov T (2009) Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations. J Med Chem 52:2836\u20132845","journal-title":"J Med Chem"},{"key":"3809_CR129","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/gut.2008.169805","volume":"59","author":"A Zilberberg","year":"2010","unstructured":"Zilberberg A, Lahav L, Rosin-Arbesfeld R (2010) Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons. Gut 59:496\u2013507","journal-title":"Gut"},{"key":"3809_CR130","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00109-001-0317-z","volume":"80","author":"KM Keeling","year":"2002","unstructured":"Keeling KM, Bedwell DM (2002) Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system. J Mol Med 80:367\u2013376","journal-title":"J Mol Med"},{"key":"3809_CR131","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1093\/nar\/gkq1277","volume":"39","author":"C Floquet","year":"2011","unstructured":"Floquet C, Deforges J, Rousset J-P, Bidou L (2011) Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides. Nucleic Acids Res 39:3350\u20133362","journal-title":"Nucleic Acids Res"},{"key":"3809_CR132","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00109-006-0045-5","volume":"84","author":"M Du","year":"2006","unstructured":"Du M, Keeling KM, Fan L, Liu X, Kova\u00e7s T, Sorscher E, Bedwell DM (2006) Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model. J Mol Med 84:573\u2013582","journal-title":"J Mol Med"},{"key":"3809_CR133","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/hmg\/ddi131","volume":"14","author":"EC Wolstencroft","year":"2005","unstructured":"Wolstencroft EC, Mattis V, Bajer AA, Young PJ, Lorson CL (2005) A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels. Hum Mol Genet 14:1199\u20131210","journal-title":"Hum Mol Genet"},{"key":"3809_CR134","first-page":"589","volume":"120","author":"VB Mattis","year":"2006","unstructured":"Mattis VB, Rai R, Wang J, Chang C-WT, Coady T, Lorson CL (2006) Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts. Hum Genomics 120:589\u2013601","journal-title":"Hum Genomics"},{"key":"3809_CR135","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/hmg\/ddp030","volume":"18","author":"CR Heier","year":"2009","unstructured":"Heier CR, DiDonato CJ (2009) Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo. Hum Mol Genet 18:1310\u20131322","journal-title":"Hum Mol Genet"},{"key":"3809_CR136","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.clpt.6100012","volume":"81","author":"LV Zingman","year":"2007","unstructured":"Zingman LV, Park S, Olson TM, Alekseev AE, Terzic A (2007) Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy. Clin Pharmacol Ther 81:99\u2013103","journal-title":"Clin Pharmacol Ther"},{"key":"3809_CR137","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/15476286.2017.1285480","volume":"14","author":"L Bidou","year":"2017","unstructured":"Bidou L, Bugaud O, Belakhov V, Baasov T, Namyb O (2017) Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells. RNA Biol 14:378\u2013388","journal-title":"RNA Biol"},{"key":"3809_CR138","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1016\/0006-2952(82)90303-3","volume":"31","author":"G Laurent","year":"1982","unstructured":"Laurent G, Carlier MB, Rollman B, Van Hoof F, Tulkens P (1982) Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem Pharmacol 31:3861\u20133870","journal-title":"Biochem Pharmacol"},{"key":"3809_CR139","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/0006-2952(95)02160-4","volume":"50","author":"EM Priuska","year":"1995","unstructured":"Priuska EM, Schacht J (1995) Formation of free radicals by gentamicin and iron and evidence for an iron\/gentamicin complex. Biochem Pharmacol 50:1749\u20131752","journal-title":"Biochem Pharmacol"},{"key":"3809_CR140","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fncel.2017.00308","volume":"11","author":"M Jiang","year":"2017","unstructured":"Jiang M, Karasawa T, Steyger PS (2017) Aminoglycoside-induced cochleotoxicity: a review. Front Cell Neurosci 11:308","journal-title":"Front Cell Neurosci"},{"key":"3809_CR141","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1073\/pnas.0707265105","volume":"105","author":"SN Hobbie","year":"2008","unstructured":"Hobbie SN, Akshay S, Kalapala SK, Bruell CM, Shcherbakov D, B\u00f6ttger EC (2008) Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity. Proc Natl Acad Sci USA 105:3244\u20133249","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR142","doi-asserted-by":"publisher","first-page":"937861","DOI":"10.1155\/2011\/937861","volume":"2011","author":"ME Huth","year":"2011","unstructured":"Huth ME, Ricci AJ, Cheng AG (2011) Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. Int J Otolaryngol 2011:937861","journal-title":"Int J Otolaryngol"},{"key":"3809_CR143","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1128\/AAC.43.5.1003","volume":"43","author":"MP Mingeot-Leclercq","year":"1999","unstructured":"Mingeot-Leclercq MP, Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003\u20131012","journal-title":"Antimicrob Agents Chemother"},{"key":"3809_CR144","first-page":"597","volume":"39","author":"EJ Begg","year":"1995","unstructured":"Begg EJ, Barclay ML (1995) Aminoglycosides\u201450 years on. Br J Clin Pharmacol 39:597\u2013603","journal-title":"Br J Clin Pharmacol"},{"key":"3809_CR145","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1172\/JCI118176","volume":"96","author":"SK Moestrup","year":"1995","unstructured":"Moestrup SK, Cui S, Vorum H, Bregeng\u00e5rd C, Bj\u00f8rn SE, Norris K, Gliemann J, Christensen EI (1995) Evidence that epithelial glycoprotein 330\/megalin mediates uptake of polybasic drugs. J Clin Invest 96:1404\u20131413","journal-title":"J Clin Invest"},{"key":"3809_CR146","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/138161207779313731","volume":"13","author":"E Selimoglu","year":"2007","unstructured":"Selimoglu E (2007) Aminoglycoside-induced ototoxicity. Curr Pharm Des 13:119\u2013126","journal-title":"Curr Pharm Des"},{"key":"3809_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/emboj\/19.1.1","volume":"19","author":"R Schroeder","year":"2000","unstructured":"Schroeder R, Waldsich C, Wank H (2000) Modulation of RNA function by aminoglycoside antibiotics. EMBO J 19:1\u20139","journal-title":"EMBO J"},{"key":"3809_CR148","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1177\/0194599811414496","volume":"145","author":"RE Clifford","year":"2011","unstructured":"Clifford RE, Coleman JKM, Balough BJ, Liu J, Kopke RD, Jackson RL (2011) Low-dose d-methionine and N-acetyl-l-cysteine for protection from permanent noise-induced hearing loss in chinchillas. Otolaryngol Head Neck Surg 145:999\u20131006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"3809_CR149","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/0974-7753.51923","volume":"1","author":"RM Tr\u00fceb","year":"2009","unstructured":"Tr\u00fceb RM (2009) Oxidative stress in ageing of hair. Int J Trichol 1:6\u201314","journal-title":"Int J Trichol"},{"key":"3809_CR150","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1128\/AAC.38.5.1027","volume":"38","author":"N Thibault","year":"1994","unstructured":"Thibault N, Grenier L, Simard M, Bergeron MG, Beauchamp D (1994) Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity. Antimicrob Agents Chemother 38:1027\u20131035","journal-title":"Antimicrob Agents Chemother"},{"key":"3809_CR151","first-page":"807","volume":"79","author":"SH Sha","year":"1999","unstructured":"Sha SH, Schacht J (1999) Salicylate attenuates gentamicin-induced ototoxicity. Lab Invest 79:807\u2013813","journal-title":"Lab Invest"},{"key":"3809_CR152","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/labinvest.3780453","volume":"82","author":"G Li","year":"2002","unstructured":"Li G, Sha S-H, Zotova E, Arezzo J, Water TVD, Schacht J (2002) Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab Invest 82:585\u2013596","journal-title":"Lab Invest"},{"key":"3809_CR153","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1248\/bpb.34.712","volume":"34","author":"M Yukihara","year":"2011","unstructured":"Yukihara M, Ito K, Tanoue O, Goto K, Matsushita T, Matsumoto Y, Masuda M, Kimura S, Ueoka R (2011) Effective drug delivery system for Duchenne muscular dystrophy using hybrid liposomes including gentamicin along with reduced toxicity. Biol Pharm Bull 34:712\u2013716","journal-title":"Biol Pharm Bull"},{"key":"3809_CR154","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/jac\/48.3.333","volume":"48","author":"R Schiffelers","year":"2001","unstructured":"Schiffelers R, Storm G, Bakker-Woudenberg I (2001) Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. J Antimicrob Chemother 48:333\u2013344","journal-title":"J Antimicrob Chemother"},{"key":"3809_CR155","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/infdis\/159.5.945","volume":"159","author":"DN Gilbert","year":"1989","unstructured":"Gilbert DN, Wood CA, Kohlhepp SJ, Kohnen PW, Houghton DC, Finkbeiner HC, Lindsley J, Bennett WM (1989) Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis 159:945\u2013953","journal-title":"J Infect Dis"},{"key":"3809_CR156","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1074\/jbc.M806728200","volume":"284","author":"M Du","year":"2009","unstructured":"Du M, Keeling KM, Fan L, Liu X, Bedwell DM (2009) Poly-l-aspartic acid enhances and prolongs gentamicin-mediated suppression of the CFTR-G542X mutation in a cystic fibrosis mouse model. J Biol Chem 284:6885\u20136892","journal-title":"J Biol Chem"},{"key":"3809_CR157","doi-asserted-by":"publisher","first-page":"6310","DOI":"10.1016\/j.bmcl.2006.09.013","volume":"16","author":"I Nudelman","year":"2006","unstructured":"Nudelman I, Rebibo-Sabbah A, Shallom-Shezifi D, Hainrichson M, Stahl I, Ben-Yosef T, Baasov T (2006) Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations. Bioorg Med Chem Lett 16:6310\u20136315","journal-title":"Bioorg Med Chem Lett"},{"key":"3809_CR158","first-page":"6671","volume":"51","author":"T Goldmann","year":"2010","unstructured":"Goldmann T, Rebibo-Sabbah A, Overlack N, Nudelman I, Belakhov V, Baasov T, Ben-Yosef T, Wolfrum U, Nagel-Wolfrum K (2010) Beneficial read-through of a USH1C nonsense mutation by designed aminoglycoside NB30 in the retina. Physiol Pharmacol 51:6671\u20136680","journal-title":"Physiol Pharmacol"},{"key":"3809_CR159","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/emmm.201201438","volume":"4","author":"T Goldmann","year":"2012","unstructured":"Goldmann T, Overlack N, M\u00f6ller F, Belakhov V, Wyk MV, Baasov T, Wolfrum U, Nagel-Wolfrum K (2012) A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation. EMBO Mol Med 4:1186\u20131199","journal-title":"EMBO Mol Med"},{"key":"3809_CR160","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00109-011-0787-6","volume":"89","author":"SM Rowe","year":"2011","unstructured":"Rowe SM, Bedwell DM (2011) Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54. J Mol Med 89:1149\u20131161","journal-title":"J Mol Med"},{"key":"3809_CR161","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1016\/j.bmc.2010.03.060","volume":"18","author":"I Nudelman","year":"2010","unstructured":"Nudelman I, Glikin D, Smolkin B, Hainrichson M, Belakhov V, Baasov T (2010) Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations. Bioorgan Med Chem 18:3735\u20133746","journal-title":"Bioorgan Med Chem"},{"key":"3809_CR162","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","volume":"89","author":"C Brendel","year":"2011","unstructured":"Brendel C, Belakhov V, Werner H, Wegener E, G\u00e4rtner J, Nudelman I, Baasov T, Huppke P (2011) Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model. J Mol Med 89:389\u2013398","journal-title":"J Mol Med"},{"key":"3809_CR163","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1093\/hmg\/ddp333","volume":"18","author":"VB Mattis","year":"2009","unstructured":"Mattis VB, Ebert AD, Fosso MY, Chang C-W, Lorson CL (2009) Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model. Hum Mol Genet 18:3906\u20133913","journal-title":"Hum Mol Genet"},{"key":"3809_CR164","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1021\/ol0269042","volume":"4","author":"C-WT Chang","year":"2004","unstructured":"Chang C-WT, Hui Y, Elchert B, Wang J, Li J, Rai R (2004) Pyranmycins, a novel class of aminoglycosides with improved acid stability: the SAR of d-pyranoses on ring III of pyranmycin. Org Lett 4:4603\u20134606","journal-title":"Org Lett"},{"key":"3809_CR165","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2202-10-142","volume":"10","author":"VB Mattis","year":"2009","unstructured":"Mattis VB, Fosso MY, Chang CW, Lorson CL (2009) Subcutaneous administration of TC007 reduces disease severity in an animal model of SMA. BMC Neurosci 10:142","journal-title":"BMC Neurosci"},{"key":"3809_CR166","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.3390\/ijms21134672","volume":"21","author":"V Bezzerri","year":"2020","unstructured":"Bezzerri V, Api M, Allegri M, Fabrizzi B, Corey SJ, Cipolli M (2020) Nonsense suppression therapy: new hypothesis for the treatment of inherited bone marrow failure syndromes. Int J Mol Sci 21:4672","journal-title":"Int J Mol Sci"},{"key":"3809_CR167","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/cpdd.647","volume":"8","author":"A Leubitz","year":"2019","unstructured":"Leubitz A, Frydman-Marom A, Sharpe N, Duzer JV, Campbell KCM, Vanhoutte F (2019) Safety, tolerability, and pharmacokinetics of single ascending doses of ELX-02, a potential treatment for genetic disorders caused by nonsense mutations, in healthy volunteers. Clin Pharmacol Drug Dev 8:984\u2013994","journal-title":"Clin Pharmacol Drug Dev"},{"key":"3809_CR168","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1165\/rcmb.2013-0282OC","volume":"50","author":"X Xue","year":"2014","unstructured":"Xue X, Mutyam V, Tang L, Rowe SM (2014) Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor. Am J Respir Cell Mol Biol 50:805\u2013816","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3809_CR169","doi-asserted-by":"publisher","first-page":"e0223954","DOI":"10.1371\/journal.pone.0223954","volume":"14","author":"EJ Brasell","year":"2019","unstructured":"Brasell EJ, Chu LL, Akpa MM, Eshkar-Oren I, Alroy I, Corsini R, Gilfix BM, Yamanaka Y, Huertas P, Goodyer P (2019) The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis. PLoS ONE 14:e0223954","journal-title":"PLoS ONE"},{"key":"3809_CR170","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature05756","volume":"447","author":"EM Welch","year":"2007","unstructured":"Welch EM, Barton ER, Zhuo J et al (2007) PTC124 targets genetic disorders caused by nonsense mutations. Nature 447:87\u201391","journal-title":"Nature"},{"key":"3809_CR171","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/0091270006297140","volume":"47","author":"S Hirawat","year":"2007","unstructured":"Hirawat S, Welch EM, Elfring GL et al (2007) Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers. J Clin Pharmacol 47:430\u2013444","journal-title":"J Clin Pharmacol"},{"key":"3809_CR172","doi-asserted-by":"publisher","first-page":"e0212121","DOI":"10.1371\/journal.pone.0212121","volume":"14","author":"M Krall","year":"2019","unstructured":"Krall M, Htun S, Slavotinek A (2019) Use of PTC124 for nonsense suppression therapy targeting BMP4 nonsense variants in vitro and the bmp4st72 allele in zebrafish. PLoS ONE 14:e0212121","journal-title":"PLoS ONE"},{"key":"3809_CR173","doi-asserted-by":"publisher","first-page":"175628641880958","DOI":"10.1177\/1756286418809588","volume":"11","author":"L Ruggiero","year":"2018","unstructured":"Ruggiero L, Iodice R, Esposito M, Dubbioso R, Tozza S, Vitale F, Santoro L, Manganelli F (2018) One-year follow up of three Italian patients with Duchenne muscular dystrophy treated with Ataluren: is earlier better? Ther Adv Neurol Disord 11:1756286418809588","journal-title":"Ther Adv Neurol Disord"},{"key":"3809_CR174","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fped.2018.00316","volume":"6","author":"D Ebrahimi-Fakhari","year":"2018","unstructured":"Ebrahimi-Fakhari D, Dillmann U, Flotats-Bastardas M, Poryo M, Abdul-Khaliq H, Shamdeen MG, Mischo B, Zemlin M, Meyer S (2018) Off-label use of Ataluren in four non-ambulatory patients with Duchenne muscular dystrophy: effects on cardiac and pulmonary function and muscle strength. Front Pediatr 6:316","journal-title":"Front Pediatr"},{"key":"3809_CR175","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev-med-120611-144851","volume":"64","author":"SW Peltz","year":"2013","unstructured":"Peltz SW, Morsy M, Welch EM, Jacobson A (2013) Ataluren as an agent for therapeutic nonsense suppression. Annu Rev Med 64:407\u2013425","journal-title":"Annu Rev Med"},{"key":"3809_CR176","doi-asserted-by":"publisher","first-page":"12508","DOI":"10.1073\/pnas.1605336113","volume":"113","author":"B Roy","year":"2016","unstructured":"Roy B, Friesen WJ, Tomizawa Y, Jacobson A (2016) Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression. Proc Natl Acad Sci USA 113:12508\u201312513","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR177","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/jgm.1140","volume":"10","author":"V Allamand","year":"2008","unstructured":"Allamand V, Pascale G (2008) Drug-induced readthrough of premature stop codons leads to the stabilization of laminin alpha2 chain mRNA in CMD myotubes. J Gene Med 10:217\u2013224","journal-title":"J Gene Med"},{"key":"3809_CR178","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1021\/acsmedchemlett.8b00558","volume":"10","author":"M Tutone","year":"2019","unstructured":"Tutone M, Pibiri I, Lentini L, Pace A (2019) Deciphering the nonsense readthrough mechanism of action of Ataluren: an insilico compared study. ACS Med Chem Lett 10:522\u2013527","journal-title":"ACS Med Chem Lett"},{"key":"3809_CR179","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1073\/pnas.0813345106","volume":"106","author":"DS Auld","year":"2009","unstructured":"Auld DS, Thorne N, Maguire WF, Inglese J (2009) Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression. Proc Natl Acad Sci USA 106:3585\u20133590","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR180","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1073\/pnas.0909141107","volume":"107","author":"DS Auld","year":"2010","unstructured":"Auld DS, Lovell S, Thorne N, Lea WA, Maloney DJ, Shen M, Rai G, Battaile KP, Thomas CJ, Simeonov A, Hanzlik RP, Inglese J (2010) Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124. Proc Natl Acad Sci USA 107:4878\u20134883","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR181","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41598-017-01093-9","volume":"7","author":"F Bolze","year":"2017","unstructured":"Bolze F, Mocek S, Zimmermann A, Klingenspor M (2017) Aminoglycosides, but not PTC124 (Ataluren), rescue nonsense mutations in the leptin receptor and in luciferase reporter genes. Sci Rep 7:1020","journal-title":"Sci Rep"},{"key":"3809_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-26481-7","volume":"8","author":"S Torriano","year":"2018","unstructured":"Torriano S, Erkilic N, Baux D, Cereso N, De Luca V, Meunier I, Moosajee M, Roux AF, Hamel CP, Kalatzis V (2018) The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy. Sci Rep 8:1\u201315","journal-title":"Sci Rep"},{"key":"3809_CR183","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1042\/BJ20111912","volume":"443","author":"SC Harmer","year":"2012","unstructured":"Harmer SC, Mohal JS, Kemp D, Tinker A (2012) Readthrough of long-QT syndrome type 1 nonsense mutations rescues function but alters the biophysical properties of the channel. Biochem J 443:635\u2013642","journal-title":"Biochem J"},{"key":"3809_CR184","doi-asserted-by":"publisher","first-page":"e004227","DOI":"10.1161\/CIRCEP.116.004227","volume":"9","author":"G Kosmidis","year":"2016","unstructured":"Kosmidis G, Veerman CC, Casini S, Verkerk AO, Pas SVD, Bellin M, Wilde AAM, Mummery CL, Bezzina CR (2016) SCN5A, Readthrough-promoting drugs gentamicin and PTC124 fail to rescue Nav1.5 function of human-induced pluripotent stem cell-derived cardiomyocytes carrying nonsense mutations in the sodium channel gene. Circ Arrhythmia Electrophysiol 9:e004227","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"3809_CR185","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7164\/antibiotics.23.170","volume":"23","author":"M Hamada","year":"1970","unstructured":"Hamada M, Takeuchi T, Kondo S, Ikeda Y, Naganawa H, Maeda K, Okami Y, Umezawa H (1970) A new antibiotic, negamycin. J Antibiot 23:170\u2013171","journal-title":"J Antibiot"},{"key":"3809_CR186","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/ja.2017.112","volume":"71","author":"A Taguchi","year":"2018","unstructured":"Taguchi A, Hamada K, Hayashi Y (2018) Chemotherapeutics overcoming nonsense mutation-associated genetic diseases: medicinal chemistry of negamycin. J Antibiot 71:205\u2013214","journal-title":"J Antibiot"},{"key":"3809_CR187","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.molcel.2014.09.021","volume":"56","author":"YS Polikanov","year":"2015","unstructured":"Polikanov YS, Szal T, Jiang F, Gupta P, Matsuda R, Shiozuka M, Steitz TA, V\u00e1zquez-Laslop N, Mankin AS (2015) Negamycin interferes with decoding and translocation by simultaneous interaction with rRNA and tRNA. Mol Cell 56:541\u2013550","journal-title":"Mol Cell"},{"key":"3809_CR188","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1128\/AAC.00455-07","volume":"51","author":"SJ Schroeder","year":"2007","unstructured":"Schroeder SJ, Blaha G, Moore PB (2007) Negamycin binds to the wall of the nascent chain exit tunnel of the 50S ribosomal subunit. Antimicrob Agents Chemother 51:4462\u20134465","journal-title":"Antimicrob Agents Chemother"},{"key":"3809_CR189","doi-asserted-by":"publisher","first-page":"937","DOI":"10.7164\/antibiotics.29.937","volume":"29","author":"Y Uehara","year":"1976","unstructured":"Uehara Y, Hori M, Kondo S, Hamada M, Umezawa H (1976) Structure-activity relationships among negamycin analogs. J Antibiot 29:937\u2013943","journal-title":"J Antibiot"},{"key":"3809_CR190","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/jb\/mvg203","volume":"134","author":"M Arakawa","year":"2003","unstructured":"Arakawa M, Shiozuka M, Nakayama Y, Hara T, Matsuda R (2003) Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice. J Biochem 134:751\u2013758","journal-title":"J Biochem"},{"key":"3809_CR191","doi-asserted-by":"publisher","first-page":"00080","DOI":"10.1183\/23120541.00080-2017","volume":"4","author":"I Pranke","year":"2018","unstructured":"Pranke I, Bidou L, Martin N et al (2018) Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons. ERJ Open Res 4:00080\u201302017","journal-title":"ERJ Open Res"},{"key":"3809_CR192","doi-asserted-by":"publisher","first-page":"e24125","DOI":"10.1371\/journal.pone.0024125","volume":"6","author":"C Floquet","year":"2011","unstructured":"Floquet C, RoussetJ-P BL (2011) Readthrough of premature termination codons in the adenomatous polyposis coli gene restores its biological activity in human cancer cells. PLoS ONE 6:e24125","journal-title":"PLoS ONE"},{"key":"3809_CR193","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1021\/ml200245t","volume":"3","author":"A Taguchi","year":"2012","unstructured":"Taguchi A, Nishiguchi S, Shiozuka M (2012) Negamycin analogue with readthrough-promoting activity as a potential drug candidate for Duchenne muscular dystrophy. ACS Med Chem Lett 3:2736\u20132740","journal-title":"ACS Med Chem Lett"},{"key":"3809_CR194","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1021\/acsmedchemlett.9b00273","volume":"10","author":"K Hamada","year":"2019","unstructured":"Hamada K, Omura N, Taguchi A, Baradaran-Heravi A, Kotake M, Arai M, Takayama K, Taniguchi A, Roberge M, Hayashi Y (2019) New negamycin-based potent readthrough derivative effective against TGA-type nonsense mutations. ACS Med Chem Lett 10:1450\u20131456","journal-title":"ACS Med Chem Lett"},{"key":"3809_CR195","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1146\/annurev.mi.42.100188.002555","volume":"42","author":"RH Baltz","year":"1988","unstructured":"Baltz RH, Seno ET (1988) Genetics of Streptomyces fradiae and tylosin biosynthesis. Annu Rev Microbiol 42:547\u2013574","journal-title":"Annu Rev Microbiol"},{"key":"3809_CR196","doi-asserted-by":"publisher","first-page":"6898","DOI":"10.1128\/JB.183.23.6898-6907.2001","volume":"183","author":"G Garza-Ramos","year":"2001","unstructured":"Garza-Ramos G, Xiong L, Zhong P, Mankin A (2001) Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA. J Bacteriol 183:6898\u20136907","journal-title":"J Bacteriol"},{"key":"3809_CR197","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1128\/AAC.48.10.3677-3683.2004","volume":"48","author":"GW Novotny","year":"2004","unstructured":"Novotny GW, Jakobsen L, Andersen NM, Poehlsgaard J, Douthwaite S (2004) Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA. Antimicrob Agents Chemother 48:3677\u20133683","journal-title":"Antimicrob Agents Chemother"},{"key":"3809_CR198","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/jac\/22.Supplement_B.13","volume":"22","author":"A Brisson-No\u00ebl","year":"1988","unstructured":"Brisson-No\u00ebl A, Trieu-Cuot P, Courvalin P (1988) Mechanism of action of spiramycin and other macrolides. J Antimicrob Chemother 22:13\u201323","journal-title":"J Antimicrob Chemother"},{"key":"3809_CR199","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/mt.2013.150","volume":"21","author":"L Du","year":"2013","unstructured":"Du L, Jung ME, Damoiseaux R, Completo G, Fike F, Ku J-M, Nahas S, Piao C, Hu H, Gatti RA (2013) A new series of small molecular weight compounds induce read through of all three types of nonsense mutations in the ATM gene. Mol Ther 21:1653\u20131660","journal-title":"Mol Ther"},{"key":"3809_CR200","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1093\/hmg\/dds223","volume":"21","author":"R Kayali","year":"2012","unstructured":"Kayali R, Ku J-M, Bertoni C (2012) Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy. Hum Mol Genet 21:4007\u20134020","journal-title":"Hum Mol Genet"},{"key":"3809_CR201","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1084\/jem.20081940","volume":"206","author":"L Du","year":"2009","unstructured":"Du L, Gatti RA (2009) Non-aminoglycoside compounds induce readthrough of nonsense mutations. J Exp Med 206:2285\u20132297","journal-title":"J Exp Med"},{"key":"3809_CR202","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1021\/acsmedchemlett.9b00609","volume":"11","author":"M Tutone","year":"2020","unstructured":"Tutone M, Pibiri I, Perriera R, Campofelice A, Culletta G, Melfi R, Pace A, Almerico AM, Lentini L (2020) Pharmacophore-based design of new chemical scaffolds as translational readthrough-inducing drugs (TRIDs). ACS Med Chem Lett 11:747\u2013753","journal-title":"ACS Med Chem Lett"},{"key":"3809_CR203","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1261\/rna.060236.116","volume":"23","author":"WJ Friesen","year":"2017","unstructured":"Friesen WJ, Trotta CR, Tomizawa Y, Zhuo J, Welch EM (2017) The nucleoside analog clitocine is a potent and efficacious readthrough agent. RNA 23:567\u2013577","journal-title":"RNA"},{"key":"3809_CR204","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/s41467-020-15140-z","volume":"11","author":"C Trzaska","year":"2020","unstructured":"Trzaska C, Amand S, Bailly C, Leroy C, Marchand V (2020) 2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations. Nat Commun 11:1509","journal-title":"Nat Commun"},{"key":"3809_CR205","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1164\/rccm.201601-0154OC","volume":"194","author":"V Mutyam","year":"2016","unstructured":"Mutyam V, Du M, Xue X, Keeling KM, White LE, Rowe SM (2016) Discovery of clinically approved agents that promote suppression of cystic fibrosis transmembrane conductance regulator nonsense mutations. Am J Respir Crit Care Med 194:1092\u20131103","journal-title":"Am J Respir Crit Care Med"},{"key":"3809_CR206","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1750-1172-7-58","volume":"7","author":"S Gonzalez-Hilarion","year":"2012","unstructured":"Gonzalez-Hilarion S, Beghyn T, Jia J, Debreuck N, Berte G, Mamchaoui K, Mouly V, Gruenert DC, D\u00e9prez B, Lejeune F (2012) Rescue of nonsense mutations by amlexanox in human cells. Orphanet J Rare Dis 7:58","journal-title":"Orphanet J Rare Dis"},{"key":"3809_CR207","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.jid.2017.05.011","volume":"137","author":"VS Atanasova","year":"2017","unstructured":"Atanasova VS, Jiang Q, Prisco M, Gruber C, South AP (2017) Amlexanox enhances premature termination codon read-through in COL7A1 and expression of full length type VII collagen: potential therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 137:1842\u20131849","journal-title":"J Invest Dermatol"},{"key":"3809_CR208","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbadis.2017.12.014","volume":"1864","author":"A Banning","year":"2018","unstructured":"Banning A, Schiff M, Tikkanen R (2018) Amlexanox provides a potential therapy for nonsense mutations in the lysosomal storage disorder aspartylglucosaminuria. Biochim Biophys Acta Mol Basis Dis 1864:668\u2013675","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3809_CR209","doi-asserted-by":"crossref","first-page":"d043281","DOI":"10.1242\/dmm.043281","volume":"13","author":"G Tarras\u00f3","year":"2020","unstructured":"Tarras\u00f3 G, Real-Martinez A, Par\u00e9s M et al (2020) Absence of p.R50X Pygm read-through in McArdle disease cellular models. Dis Model Mech 13:d043281","journal-title":"Dis Model Mech"},{"key":"3809_CR210","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.gene.2014.11.034","volume":"556","author":"K Rijal","year":"2015","unstructured":"Rijal K, Maraia RJ, Arimbasseri AG (2015) A methods review on use of nonsense suppression to study 3\u2032 end formation and other aspects of tRNA biogenesis. Gene 556:35\u201350","journal-title":"Gene"},{"key":"3809_CR211","doi-asserted-by":"publisher","first-page":"5857","DOI":"10.1038\/296537a0","volume":"296","author":"GF Temple","year":"1982","unstructured":"Temple GF, Dozy AM, Roy KL, Kan YW (1982) Construction of a functional human suppressor tRNA gene: an approach to gene therapy for beta-thalassaemia. Nature 296:5857","journal-title":"Nature"},{"key":"3809_CR212","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/nass\/nrl119","volume":"50","author":"Y Sako","year":"2006","unstructured":"Sako Y, Usuki F, Suga H (2006) A novel therapeutic approach for genetic diseases by introduction of suppressor tRNA. Nucleic Acids Symp Ser 50:239\u2013240","journal-title":"Nucleic Acids Symp Ser"},{"key":"3809_CR213","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1023\/A:1014238221426","volume":"36","author":"AV Kiselev","year":"2002","unstructured":"Kiselev AV, Ostapenko OV, Rogozhkina EV, Kholod NS, Seit-Nebi AS, Baranov AN (2002) Suppression of nonsense mutations in the dystrophin gene by a suppressor tRNA gene. Mol Biol 36:30\u201333","journal-title":"Mol Biol"},{"key":"3809_CR214","doi-asserted-by":"publisher","unstructured":"Lueck JD, Infield DT, Mackey AL, Pope MR, McCray PB, Ahern CA (2016) Engineered tRNA suppression of a CFTR nonsense mutation. In: bioRxiv. https:\/\/www.biorxiv.org\/content\/https:\/\/doi.org\/10.1101\/088690v1. Accessed 24 Aug 2020","DOI":"10.1101\/088690v1"},{"key":"3809_CR215","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1089\/10430349950017194","volume":"10","author":"RG Panchal","year":"1999","unstructured":"Panchal RG, Wang S, McDermott J Jr, Link CJ (1999) Partial functional correction of xeroderma pigmentosum group A cells by suppressor tRNA. Hum Gene Ther 10:2209\u20132219","journal-title":"Hum Gene Ther"},{"key":"3809_CR216","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/ejhg.2013.292","volume":"22","author":"R Bordeira-Carri\u00e7o","year":"2014","unstructured":"Bordeira-Carri\u00e7o R, Ferreira D, Oliveira C (2014) Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA. Eur J Hum Genet 22:1085\u20131092","journal-title":"Eur J Hum Genet"},{"key":"3809_CR217","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41467-019-08329-4","volume":"10","author":"JD Lueck","year":"2019","unstructured":"Lueck JD, Yoon JS, Perales-Puchalt A, Mackey AL, Infield DT, Ahern CA (2019) Engineered transfer RNAs for suppression of premature termination codons. Nat Commun 10:822","journal-title":"Nat Commun"},{"key":"3809_CR218","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/j.jcf.2017.10.017","volume":"17","author":"MC Hagemeijer","year":"2018","unstructured":"Hagemeijer MC, Siegwart DJ, Strug LJ, Cebotaru L, Torres MJ, Sofoluwe A, Beekman JM (2018) Translational research to enable personalized treatment of cystic fibrosis. J Cyst Fibros 17:S46\u2013S51","journal-title":"J Cyst Fibros"},{"key":"3809_CR219","doi-asserted-by":"publisher","first-page":"6714","DOI":"10.1128\/JB.186.20.6714-6720.2004","volume":"186","author":"CD Herring","year":"2004","unstructured":"Herring CD, Blattner FR (2004) Global transcriptional effects of a suppressor tRNA and the inactivation of the regulator frmR. J Bacteriol 186:6714\u20136720","journal-title":"J Bacteriol"},{"key":"3809_CR220","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0092-8674(00)80263-9","volume":"89","author":"P Ganot","year":"1997","unstructured":"Ganot P, Bortolin ML, Kiss T (1997) Site-specific pseudouridine formation in preribosomal RNA is guided by small nucleolar RNAs. Cell 89:799\u2013809","journal-title":"Cell"},{"key":"3809_CR221","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.molcel.2010.01.032","volume":"37","author":"T Kiss","year":"2010","unstructured":"Kiss T, J\u00e1dy BE (2010) Box H\/ACA small ribonucleoproteins. Mol Cell 37:597\u2013606","journal-title":"Mol Cell"},{"key":"3809_CR222","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/bs.enz.2017.02.001","volume":"41","author":"MD De Zoysa","year":"2017","unstructured":"De Zoysa MD, Yu YT (2017) Posttranscriptional RNA pseudouridylation. Enzymes 41:151\u2013167","journal-title":"Enzymes"},{"key":"3809_CR223","first-page":"210","volume":"38","author":"G Junhui","year":"2014","unstructured":"Junhui G, Yi-Tao Y (2014) RNA pseudouridylation: new insights into an old modification. Trends Biochem Sci 38:210\u2013218","journal-title":"Trends Biochem Sci"},{"key":"3809_CR224","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1261\/rna.066837.118","volume":"24","author":"MD De Zoysa","year":"2018","unstructured":"De Zoysa MD, Wu G, Katz R, Yu Y-T (2018) Guide-substrate base-pairing requirement for box H\/ACA RNA-guided RNA pseudouridylation. RNA 24:1106\u20131117","journal-title":"RNA"},{"key":"3809_CR225","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nprot.2012.029","volume":"7","author":"C Huang","year":"2012","unstructured":"Huang C, Wu G, Yu YT (2012) Inducing nonsense suppression by targeted pseudouridylation. Nat Protoc 7:789\u2013800","journal-title":"Nat Protoc"},{"key":"3809_CR226","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1261\/rna.076042.120","volume":"26","author":"H Adachi","year":"2020","unstructured":"Adachi H, Yu Y-T (2020) Pseudouridine-mediated stop codon read-through in S. cerevisiae is sequence context-independent. RNA 26:1247\u20131256","journal-title":"RNA"},{"key":"3809_CR227","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/0092-8674(86)90063-2","volume":"46","author":"R Benne","year":"1986","unstructured":"Benne R, Van den Burg J, Brakenhoff JP, Sloof P, Van Boom JH, Tromp MC (1986) Major transcript of the frameshifted coxII gene from trypanosome mitochondria contains four nucleotides that are not encoded in the DNA. Cell 46:819\u2013826","journal-title":"Cell"},{"key":"3809_CR228","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1017\/S1355838200000200","volume":"6","author":"M Ohman","year":"2000","unstructured":"Ohman M, Kallman AM, Bass BL (2000) In vitro analysis of the binding of ADAR2 to the pre-mRNA encoding the GluR-B R\/G site. RNA 6:687\u2013697","journal-title":"RNA"},{"key":"3809_CR229","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3389\/fendo.2018.00762","volume":"9","author":"C-P Kung","year":"2018","unstructured":"Kung C-P, Leonard BM Jr, Weber JD (2018) The role of RNA editing in cancer development and metabolic disorders. Front Endocrinol 9:762","journal-title":"Front Endocrinol"},{"key":"3809_CR230","first-page":"16","volume":"1","author":"MF Montiel-Gonzalez","year":"2020","unstructured":"Montiel-Gonzalez MF, Quiroz JFD, Rosenthal JJC (2020) Current strategies for site-directed RNA editing using ADARs. Methods 1:16\u201324","journal-title":"Methods"},{"key":"3809_CR231","first-page":"2797","volume":"45","author":"J Wettengel","year":"2017","unstructured":"Wettengel J, Reautschnig P, Geisler S, Kahle PJ, Stafforst T (2017) Harnessing human ADAR2 for RNA repair\u2014recoding a PINK1 mutation rescues mitophagy. Nucleic Acids Res 45:2797\u20132808","journal-title":"Nucleic Acids Res"},{"key":"3809_CR232","first-page":"e157","volume":"44","author":"MF Montiel-Gonz\u00e1lez","year":"2016","unstructured":"Montiel-Gonz\u00e1lez MF, Vallecillo-Viejo IC, Rosenthal JJC (2016) An efficient system for selectively altering genetic information within mRNAs. Nucleic Acids Res 44:e157","journal-title":"Nucleic Acids Res"},{"key":"3809_CR233","first-page":"535","volume":"15","author":"P Vogel","year":"2018","unstructured":"Vogel P, Moschref M, Li Q, Merkle T, Selvasaravanan KD, Li JB, Stafforst T (2018) Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs. Nat Med 15:535\u2013538","journal-title":"Nat Med"},{"key":"3809_CR234","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1073\/pnas.48.4.613","volume":"48","author":"C Basilio","year":"1962","unstructured":"Basilio C, Wahba AJ, Lengyel P, Speyer JF, Ochoa S (1962) Synthetic polynucleotides and the amino acid code. Proc Natl Acad Sci USA 48:613\u2013616","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR235","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/protein\/gzz005","volume":"31","author":"S Bhakta","year":"2018","unstructured":"Bhakta S, Azad TA, Tsukahara T (2018) Genetic code restoration by artificial RNA editing of Ochre stop codon with ADAR1 deaminase. Protein Eng Des Sel 31:471\u2013478","journal-title":"Protein Eng Des Sel"},{"key":"3809_CR236","doi-asserted-by":"publisher","first-page":"18285","DOI":"10.1073\/pnas.1306243110","volume":"110","author":"MF Montiel-Gonzalez","year":"2013","unstructured":"Montiel-Gonzalez MF, Vallecillo-Viejo I, Yudowski GA, Rosenthal JJC (2013) Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. Proc Natl Acad Sci USA 110:18285\u201318290","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR237","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1126\/science.aaq0180","volume":"358","author":"DBT Cox","year":"2017","unstructured":"Cox DBT (2017) RNA editing with CRISPR-Cas13. Science 358:1019\u20131027","journal-title":"Science"},{"key":"3809_CR238","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cell.2018.09.001","volume":"175","author":"C Zhang","year":"2018","unstructured":"Zhang C, Konermann S (2018) Structural basis for the RNA-guided ribonuclease activity of CRISPR-Cas13d. Cell 175:212\u2013223","journal-title":"Cell"},{"key":"3809_CR239","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"H Li","year":"2020","unstructured":"Li H, Yang Y, Hong W, Huang M, Wu M, Zhao X (2020) Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects. Signal Transduct Target Ther 5:1\u201323","journal-title":"Signal Transduct Target Ther"},{"key":"3809_CR240","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/genetics\/122.3.519","volume":"122","author":"N Rudin","year":"1989","unstructured":"Rudin N, Sugarman E, Haber JE (1989) Genetic and physical analysis of double-strand break repair and recombination in Saccharomyces cerevisiae. Genetics 122:519\u2013534","journal-title":"Genetics"},{"key":"3809_CR241","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1126\/science.2660260","volume":"244","author":"MR Capecchi","year":"1989","unstructured":"Capecchi MR (1989) Altering the genome by homologous recombination. Science 244:1288\u20131292","journal-title":"Science"},{"key":"3809_CR242","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nature03556","volume":"435","author":"FD Urnov","year":"2005","unstructured":"Urnov FD, Miller JC, Lee Y-L (2005) Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435:646\u2013651","journal-title":"Nature"},{"key":"3809_CR243","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.1178811","volume":"326","author":"J Boch","year":"2009","unstructured":"Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A, Bonas U (2009) Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326:1509\u20131512","journal-title":"Science"},{"key":"3809_CR244","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev-biochem-060713-035418","volume":"83","author":"D Carroll","year":"2014","unstructured":"Carroll D (2014) Genome engineering with targetable nucleases. Annu Rev Biochem 83:409\u2013439","journal-title":"Annu Rev Biochem"},{"key":"3809_CR245","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran AF, Cox D, Lin S, Barretto R, Habib N, Zhang F (2013) Multiplex genome engineering using CRISPR\/Cas systems. Science 339:819\u2013823","journal-title":"Science"},{"key":"3809_CR246","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1101\/gr.171322.113","volume":"24","author":"S Kim","year":"2014","unstructured":"Kim S, Kim D, Cho SW, Kim J, Kim J-S (2014) Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res 24:1012\u20131019","journal-title":"Genome Res"},{"key":"3809_CR247","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157:1262\u20131278","journal-title":"Cell"},{"key":"3809_CR248","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mib.2017.05.008","volume":"37","author":"EV Koonin","year":"2017","unstructured":"Koonin EV, Makarova KS, Zhang F (2017) Diversity, classification and evolution of CRISPR-Cas systems. Curr Opin Microbiol 37:67\u201378","journal-title":"Curr Opin Microbiol"},{"key":"3809_CR249","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nmeth.2649","volume":"10","author":"P Mali","year":"2013","unstructured":"Mali P, Esvelt KM, Church GM (2013) Cas9 as a versatile tool for engineering biology. Nat Methods 10:957\u2013963","journal-title":"Nat Methods"},{"key":"3809_CR250","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I et al (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816\u2013821","journal-title":"Science"},{"key":"3809_CR251","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.370.6514.271","volume":"370","author":"J Cohen","year":"2020","unstructured":"Cohen J (2020) A cut above: pair that developed CRISPR earns historic award. Science 370:271\u2013272","journal-title":"Science"},{"key":"3809_CR252","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41467-018-04252-2","volume":"9","author":"M Adli","year":"2018","unstructured":"Adli M (2018) The CRISPR tool kit for genome editing and beyond. Nat Commun 9:1911","journal-title":"Nat Commun"},{"key":"3809_CR253","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1126\/science.1254445","volume":"345","author":"C Long","year":"2015","unstructured":"Long C, McAnally JR, Shelton JM, Mireault AA, Bassel-Duby R, Olson EN (2015) Prevention of muscular dystrophy in mice by CRISPR\/Cas9\u2013mediated editing of germline DNA. Science 345:1184\u20131188","journal-title":"Science"},{"key":"3809_CR254","doi-asserted-by":"publisher","first-page":"eaax1210","DOI":"10.1126\/sciadv.aax1210","volume":"5","author":"DH Jo","year":"2019","unstructured":"Jo DH, Song DW, Cho CS et al (2019) CRISPR-Cas9-mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis. Sci Adv 5:eaax1210","journal-title":"Sci Adv"},{"key":"3809_CR255","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.omtm.2020.05.002","volume":"17","author":"S Erwood","year":"2020","unstructured":"Erwood S, Laselva O, Bily TMI, Brewer RA, Rutherford AH, Bear CE, Ivakine EA (2020) Allele-specific prevention of nonsense-mediated decay in cystic fibrosis using homology-independent genome editing. Mol Ther Methods Clin Dev 17:1118\u20131128","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3809_CR256","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1089\/hum.2015.29002.fzh","volume":"26","author":"F Zhang","year":"2015","unstructured":"Zhang F (2015) CRISPR\/Cas9: prospects and challenges. Hum Gene Ther 26:409\u2013410","journal-title":"Hum Gene Ther"},{"key":"3809_CR257","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2174\/1381612823666161122142950","volume":"23","author":"A Islam","year":"2017","unstructured":"Islam A (2017) Therapeutic suppression of nonsense mutation: an emerging target in multiple diseases and thrombotic disorders. Curr Pharm Des 23:1598\u20131609","journal-title":"Curr Pharm Des"},{"key":"3809_CR258","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI28523","volume":"117","author":"L Linde","year":"2007","unstructured":"Linde L, Boelz S, Nissim-Rafinia M, Kerem B (2007) Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin. J Clin Invest 117:683\u2013692","journal-title":"J Clin Invest"},{"key":"3809_CR259","first-page":"1000172","volume":"9","author":"KA Turner","year":"2015","unstructured":"Turner KA, Choy FYM (2015) Treatment of nonsense mutations using stop codon read-through therapeutics and creation of animal models using CRISPR-Cas9. J Mol Genet Med 9:1000172","journal-title":"J Mol Genet Med"},{"key":"3809_CR260","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000343086","volume":"3","author":"B P\u00e9rez","year":"2012","unstructured":"P\u00e9rez B, Rodr\u00edguez-Pombo P, Ugarte M, Desviat LR (2012) Readthrough strategies for therapeutic suppression of nonsense mutations in inherited metabolic disease. Mol Syndr 3:230\u2013236","journal-title":"Mol Syndr"},{"key":"3809_CR261","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/ana.20107","volume":"55","author":"F Usuki","year":"2004","unstructured":"Usuki F, Yamashita A, Higuchi I, Ohnishi T, Shiraishi T, Osame M, Ohno S (2004) Inhibition of nonsense-mediated mRNA decay rescues the phenotype in Ullrich\u2019s disease. Ann Neurol 55:740\u2013744","journal-title":"Ann Neurol"},{"key":"3809_CR262","doi-asserted-by":"publisher","first-page":"e01963","DOI":"10.1016\/j.heliyon.2019.e01963","volume":"5","author":"L Lentini","year":"2019","unstructured":"Lentini L, Melfi R, Cancemi P, Pibiri I, Leonardo AD (2019) Caffeine boosts Ataluren\u2019s readthrough activity. Heliyon 5:e01963","journal-title":"Heliyon"},{"key":"3809_CR263","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ymthe.2006.04.011","volume":"14","author":"F Usuki","year":"2006","unstructured":"Usuki F, Yamashita A, Kashima I, Higuchi I, Osame M, Ohno S (2006) Specific inhibition of nonsense-mediated mRNA decay components, SMG-1 or Upf1, rescues the phenotype of Ullrich disease fibroblasts. Mol Ther 14:351\u2013360","journal-title":"Mol Ther"},{"key":"3809_CR264","doi-asserted-by":"publisher","first-page":"15037","DOI":"10.1073\/pnas.1300654110","volume":"110","author":"F Usuki","year":"2013","unstructured":"Usuki F, Yamashita A, Shiraishi T, Shiga A, Onodera O, Higuchi I, Ohno S (2013) Inhibition of SMG-8, a subunit of SMG-1 kinase, ameliorates nonsense-mediated mRNA decay-exacerbated mutant phenotypes without cytotoxicity. Proc Natl Acad Sci USA 110:15037\u201315042","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR265","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.yjmcc.2010.10.022","volume":"50","author":"Q Gong","year":"2011","unstructured":"Gong Q, Stump MR, Zhou Z (2011) Inhibition of nonsense-mediated mRNA decay by antisense morpholino oligonucleotides restores functional expression of hERG nonsense and frameshift mutations in long QT syndrome. J Mol Cell Cardiol 50:223\u2013229","journal-title":"J Mol Cell Cardiol"},{"key":"3809_CR266","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1042\/BST0381500","volume":"38","author":"M Vicente-Crespo","year":"2012","unstructured":"Vicente-Crespo M, Palacios IM (2012) Nonsense-mediated mRNA decay and development: shoot the messenger to survive? Biochem Soc Trans 38:1500\u20131505","journal-title":"Biochem Soc Trans"},{"key":"3809_CR267","doi-asserted-by":"publisher","first-page":"e60478","DOI":"10.1371\/journal.pone.0060478","volume":"8","author":"KM Keeling","year":"2013","unstructured":"Keeling KM, Wang D, Dai Y, Murugesan S, Chenna B, Clark J, Bedwell DM (2013) Attenuation of nonsense-mediated mRNA decay enhances in vivo nonsense suppression. PLoS ONE 8:e60478","journal-title":"PLoS ONE"},{"key":"3809_CR268","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1093\/nar\/gkw638","volume":"44","author":"A Baradaran-Heravi","year":"2016","unstructured":"Baradaran-Heravi A, Balgi AD (2016) Novel small molecules potentiate premature termination codon readthrough by aminoglycosides. Nucleic Acids Res 44:6583\u20136598","journal-title":"Nucleic Acids Res"},{"key":"3809_CR269","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1021\/acsmedchemlett.8b00610","volume":"10","author":"SM Rabea","year":"2019","unstructured":"Rabea SM, Baradaran-Heravi A, Balgi AD, Krause A, Farahabadi SH, Roberge M, Grierson DS (2019) 2-Aminothiazole-4-carboxamides enhance readthrough of premature termination codons by aminoglycosides. ACS Med Chem Lett 10:726\u2013731","journal-title":"ACS Med Chem Lett"},{"key":"3809_CR270","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13402-018-0379-3","volume":"41","author":"AI Teles Siefers","year":"2018","unstructured":"Teles Siefers AI, Condinho M, Cust\u00f3dio S, Pereira BF, Fernandes R, Gon\u00e7alves V, Costa PJ, Lacerda R, Marques AR, Rom\u00e3o L (2018) Genetics of personalized medicine: cancer and rare diseases. Cell Oncol 41:335\u2013341","journal-title":"Cell Oncol"},{"key":"3809_CR271","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1172\/JCI7866","volume":"104","author":"ER Barton-Davis","year":"1999","unstructured":"Barton-Davis ER, Cordier L, Shoturma DI, Leland SE, Sweeney LH (1999) Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 104:375\u2013381","journal-title":"J Clin Invest"},{"key":"3809_CR272","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3892\/ijmm.2013.1601","volume":"33","author":"H Yu","year":"2013","unstructured":"Yu H, Liu X, Huang J, Zhang Y, Hu R, Pu J (2013) Comparison of read-through effects of aminoglycosides and PTC124 on rescuing nonsense mutations of HERG gene associated with long QT syndrome. Int J Mol Med 33:729\u2013735","journal-title":"Int J Mol Med"},{"key":"3809_CR273","doi-asserted-by":"publisher","first-page":"15394","DOI":"10.1073\/pnas.0610878104","volume":"104","author":"C Yang","year":"2007","unstructured":"Yang C, Feng J, Sommer SS (2007) A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin. Proc Natl Acad Sci USA 104:15394\u201315399","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR274","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00109-002-0363-1","volume":"80","author":"M Du","year":"2002","unstructured":"Du M, Bedwell DM (2002) Aminoglycoside suppression of a premature stop mutation in a Cftr\u2212\/\u2212 mouse carrying a human CFTR-G542X transgene. J Mol Med 80:595\u2013604","journal-title":"J Mol Med"},{"key":"3809_CR275","doi-asserted-by":"publisher","first-page":"19483","DOI":"10.1073\/pnas.1312088110","volume":"110","author":"C Kuschal","year":"2013","unstructured":"Kuschal C, DiGiovanna JJ, Khan SG, Gatti RA, Kraemer KH (2013) Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons. Proc Natl Acad Sci USA 110:19483\u201319488","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR276","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1182\/blood-2005-03-1307","volume":"106","author":"PD James","year":"2005","unstructured":"James PD, Raut S, Rivard GE, Poon M-C, Warner M, McKenna S, Leggo J, Lillicrap D (2005) Aminoglycoside suppression of nonsense mutations in severe hemophilia. Blood 106:3043\u20133048","journal-title":"Blood"},{"key":"3809_CR277","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.jid.5700031","volume":"126","author":"R Kellermayer","year":"2006","unstructured":"Kellermayer R, Szigeti R, Keeling KM, Bedekovics T, Bedwell DM (2006) Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey\u2013Hailey disease. J Invest Dermatol 126:229\u2013231","journal-title":"J Invest Dermatol"},{"key":"3809_CR278","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1056\/NEJMoa022170","volume":"349","author":"M Wilschanski","year":"2003","unstructured":"Wilschanski M, Kerem E (2003) Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med 349:1433\u20131441","journal-title":"N Engl J Med"},{"key":"3809_CR279","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1164\/ajrccm.163.7.2004001","volume":"163","author":"JP Clancy","year":"2001","unstructured":"Clancy JP, Beb\u00f6k Z, Ruiz F et al (2001) Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis. Am J Respir Crit Care Med 163:1683\u20131692","journal-title":"Am J Respir Crit Care Med"},{"key":"3809_CR280","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1080\/15476286.2019.1632633","volume":"16","author":"M Fazzari","year":"2019","unstructured":"Fazzari M, Frasca A, Bifari F, Landsberger N (2019) Aminoglycoside drugs induce efficient read-through of CDKL5 nonsense mutations, slightly restoring its kinase activity. RNA Biol 16:1414\u20131423","journal-title":"RNA Biol"},{"key":"3809_CR281","doi-asserted-by":"publisher","first-page":"e6536","DOI":"10.1073\/pnas.1803154115","volume":"115","author":"V Lincoln","year":"2018","unstructured":"Lincoln V, Cogan J, Hou Y, Hirsch M, Chen M (2018) Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa. Proc Natl Acad Sci USA 115:e6536\u2013e6545","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR282","doi-asserted-by":"publisher","first-page":"F633","DOI":"10.1152\/ajprenal.00015.2008","volume":"295","author":"R Azimov","year":"2008","unstructured":"Azimov R, Abuladze N, Sassani P, Newman D, Kao L, Liu W, Orozco N, Ruchala P, Pushkin A, Kurtz I (2008) G418-mediated ribosomal read-through of a nonsense mutation causing autosomal recessive proximal renal tubular acidosis. Am J Physiol Renal Physiol 295:F633\u2013F641","journal-title":"Am J Physiol Renal Physiol"},{"key":"3809_CR283","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fonc.2017.00323","volume":"7","author":"M Zhang","year":"2018","unstructured":"Zhang M, Heldin A, Palomar-Siles M, \u00d6hlin S, Bykov VJN, Wiman KG (2018) Synergistic rescue of nonsense mutant tumor suppressor p53 by combination treatment with aminoglycosides and Mdm2 inhibitors. Front Oncol 7:323","journal-title":"Front Oncol"},{"key":"3809_CR284","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/15476286.2016.1219832","volume":"13","author":"Z Bukowy-Bieryllo","year":"2016","unstructured":"Bukowy-Bieryllo Z, Dabrowski M, Witt M, Zietkiewicz E (2016) Aminoglycoside-stimulated readthrough of premature termination codons in selected genes involved in primary ciliary dyskinesia. RNA Biol 13:1041\u20131050","journal-title":"RNA Biol"},{"key":"3809_CR285","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1177\/0883073810371129","volume":"25","author":"RS Finkel","year":"2013","unstructured":"Finkel RS (2013) Readthrough strategies for suppression of nonsense mutations in Duchenne\/Becker muscular dystrophy: aminoglycosides and Ataluren (PTC124). J Child Neurol 25:1158\u20131164","journal-title":"J Child Neurol"},{"key":"3809_CR286","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1073\/pnas.0711795105","volume":"105","author":"M Du","year":"2008","unstructured":"Du M, Liu X, Welch EM, Hirawat S, Peltz SW, Bedwell DM (2008) PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model. Proc Natl Acad Sci USA 105:2064\u20132069","journal-title":"Proc Natl Acad Sci USA"},{"key":"3809_CR287","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1165\/rcmb.2013-0100OC","volume":"49","author":"KM Drake","year":"2013","unstructured":"Drake KM, Dunmore BJ, McNelly LN, Morrell NW, Aldred MA (2013) Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension. Am J Respir Cell Mol Biol 49:403\u2013409","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3809_CR288","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2045894020935783","volume":"10","author":"L Long","year":"2020","unstructured":"Long L, Yang X, Southwood M, Moore S, Crosby A, Upton PD, Dunmore BJ, Morrell NW (2020) Targeting translational read-through of premature termination mutations in BMPR2 with PTC124 for pulmonary arterial hypertension. Pulm Circ 10:1\u201314","journal-title":"Pulm Circ"},{"key":"3809_CR289","doi-asserted-by":"publisher","first-page":"e1198","DOI":"10.1002\/mgg3.1198","volume":"8","author":"X Liu","year":"2020","unstructured":"Liu X, Zhang Y, Zhang B, Gao H, Qiu C (2020) Nonsense suppression induced readthrough of a novel PAX6 mutation in patient-derived cells of congenital aniridia. Mol Genet Genomic Med 8:e1198","journal-title":"Mol Genet Genomic Med"},{"key":"3809_CR290","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.ymgme.2014.12.026","volume":"114","author":"D Bedwell","year":"2015","unstructured":"Bedwell D, Wang D, Welch E, Keeling KM (2015) The nonsense suppression drug PTC124 restored alpha-l-iduronidase activity and reduces glycosaminoglycan accumulation in MPS IH mice carrying the Idua-W402X mutation. Mol Genet Metab 114:S20","journal-title":"Mol Genet Metab"},{"key":"3809_CR291","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0140-6736(08)61168-X","volume":"372","author":"E Kerem","year":"2008","unstructured":"Kerem E, Hirawat S, Armoni S, Yaakov Y, Shoseyov D, Wilschanski M (2008) Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet 372:719\u2013727","journal-title":"Lancet"},{"key":"3809_CR292","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jcf.2020.01.007","volume":"19","author":"MW Konstan","year":"2020","unstructured":"Konstan MW, VanDevanter DR, Rowe SM et al (2020) Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: the international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in cystic fibrosis (ACT CF). J Cyst Fibros 19:595\u2013601","journal-title":"J Cyst Fibros"},{"key":"3809_CR293","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S2213-2600(14)70100-6","volume":"2","author":"E Kerem","year":"2014","unstructured":"Kerem E, Konstan MW, De Boeck K, Accurso FJ, Sermet-Gaudelus I, Wilschanski M, Elborn JS, Melotti P, Bronsveld I, Fajac I, Malfroot A, Rosenbluth DB, Walker PA, McColley SA, Knoop C, Quattrucci S, Rietschel E, Zeitlin PL, Barth J, Elfring GL, Welch EM, Branstrom A, Spiegel RJ, Peltz SW, Ajayi T, Rowe SM, Cystic Fibrosis Ataluren Study Group (2014) Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Respir Med 2:539\u2013547","journal-title":"Lancet Respir Med"},{"key":"3809_CR294","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1183\/09031936.00120910","volume":"38","author":"M Wilschanski","year":"2011","unstructured":"Wilschanski M, Miller LL, Shoseyov D et al (2011) Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. Eur Respir J 38:59\u201369","journal-title":"Eur Respir J"},{"key":"3809_CR295","doi-asserted-by":"publisher","first-page":"e81302","DOI":"10.1371\/journal.pone.0081302","volume":"8","author":"RS Finkel","year":"2013","unstructured":"Finkel RS, Flanigan KM, Wong B et al (2013) Phase 2a study of Ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy. PLoS ONE 8:e81302","journal-title":"PLoS ONE"},{"key":"3809_CR296","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/mus.24332","volume":"50","author":"K Bushby","year":"2014","unstructured":"Bushby K (2014) Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve 50:477\u2013487","journal-title":"Muscle Nerve"},{"key":"3809_CR297","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","volume":"390","author":"CM McDonald","year":"2017","unstructured":"McDonald CM, Campbell C, Torricelli RE, Finkel RS, Flanigan KM, Goemans N, Mercuri E (2017) Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390:1489\u20131498","journal-title":"Lancet"},{"key":"3809_CR298","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00109-015-1364-1","volume":"94","author":"M Caspi","year":"2016","unstructured":"Caspi M, Firsow A, Rajkumar R, Skalka N, Moshkovitz I, Munitz A, Pasmanik-Chor M, Greif H, Megido D, Kariv R, Rosenberg DW, Rosin-Arbesfeld R (2016) A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents. J Mol Med 94:469\u2013482","journal-title":"J Mol Med"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-03809-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-021-03809-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-03809-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T10:03:24Z","timestamp":1724666604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-021-03809-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":298,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3809"],"URL":"https:\/\/doi.org\/10.1007\/s00018-021-03809-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739795168.793584412","asserted-by":"object"}]},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,22]]},"assertion":[{"value":"18 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare\u00a0that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}